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ABSTRACT I 
 
ABSTRACT 
Part I: A synthetic platform for the total synthesis of the structurally related tetracyclic meroterpenoids 
stachyflin, aureol, smenoqualone, strongylin A, and cyclosmenospongine was developed. Our synthetic 
strategy employed an auxiliary-controlled Diels–Alder reaction between V and VI to enable the 
enantioselective construction of the decalin subunit, which is connected to variously substituted arenes 
(IV) by either carbonyl addition chemistry or sterically demanding sp2–sp3 cross-coupling reactions. 
The selective installation of either the cis- or trans-decalin I or II stereochemistry was accomplished by 
an acid-mediated cyclization/isomerization reaction. This highly modular synthetic platform enabled the 
synthesis of each of these natural products and 15 non-natural derivatives. Biological profiling reveals 
that strongylin A and a simplified derivative had potent antibiotic activity against methicillin-resistant 
Staphylococcus aureus.  
 
The effective concentrations (EC50 values) that inhibited the growth of two MRSA strains (DSM 11822/RKI 11-02670) are given in µM. 
  
ABSTRACT II 
 
Part II: In the second part of this thesis, the development of a synthetic route towards the total synthesis 
of cornexistin is described. Retrosynthetically, the complex nine-membered ring can be dissected into 
three building blocks VII, VIII and IX. Starting with the construction of the eastern part of cornexistin, 
VIII and IX were reacted in a syn-Evans-aldol reaction and X was further transformed into aldehyde 
XI. At this stage, the third building block VII was introduced via an intermolecular NHK reaction giving 
two diastereoisomers α-XII and β-XII. The cyclization precursor α-XIII was synthesized seven in seven 
linear steps. An exhaustive screen of reactions conditions revealed the formation of the nine-membered 
carbocycle α-XIV by treatment with DBU in acetonitrile. Upon treatment of α-XIV with triflic chloride, 
chloride α-XV was formed instead of the desired enoltriflate. The former is envisioned to undergo 
should undergo palladium catalyzed carbonylation reaction to form the anhydride moiety of the natural 
product. Global deprotection and oxidation state adjustment at C-1 would lead to the first total synthesis 
of cornexistin.  
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A MODULAR SYNTHESIS OF TETRACYCLIC 
MEROTERPENOID ANTIBIOTICS 
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1.1 Introduction 
1.1.1 Antibiotics 
The discovery and production of antibiotics (from ancient Greek αντιβιοτικά, antibiotiká) belongs to 
mankind greatest achievements, revolutionizing medicine in the 20th century. Since the discovery of 
penicillin by Alexander Fleming in 1928, a variety of antibiotics has been developed (Figure 1). In the 
last decades, the world’s supply of antibiotics has been weakened by bacteria evolving resistance to 
these drugs.1 This is favored due to the ever-increasing prescription against nonbacterial infections and 
unregulated use, both applying a selective pressure on bacteria to build resistance to those drugs.2 The 
growing resistance of bacteria against antibiotics can be explained by Charles Darwin’s quote: “Survival 
of the fittest”. 
 
 
Figure 1 | Selected antibiotics from the modern era. 
 
Antibiotics in bacteria cells can affect their target by inhibition of the cell wall synthesis, protein 
synthesis, and DNA/RNA synthesis.3 Bacteria that survive antibiotic-induced death form the next 
generation of bacteria through cell division and the mechanisms of resistance are shared by horizontal 
gene transfer.4 Those resistance mechanisms can be divided in three general groups: limited permeability 
of the cell membrane and efflux pumps by the drug, mutation of the binding site and more efficient 
                                                     
1 For a review see: S. E. Rossiter, M. H. Fletcher, W. M. Wuest, Chem. Rev. 2017, 117, 12415−12474. 
2 a) H. C. Neu, Science 1992, 257, 1064−1073. b) B. Spellberg, D. N. Gilbert, Clin. Infect. Dis. 2014, 59, 71−75. c) V. K. 
Viswanathan, Gut Microbes 2014, 5, 3−4. 
3 a) C. Walsh, C. Antibiotics: Actions, Origins, Resistance; ASM Press: Washington, DC, 2003. b) C. Walsh, T. A. Wencewicz, 
Antibiotics: Challenges, Mechanisms, Opportunities; ASM Press: Washington, DC, 2016. 
4 T. S. Crofts, A. J. Gasparrini, G. Dantas, Nat. Rev. Microbiol. 2017, 15, 422−434. 
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degradation of the drug in the cell.5 In this course, natural products have often been the foundation for 
the development of new antibiotics for example tetracycline (2), erythromycin (4) and clindamycin (7). 
The antibiotics sulfamethizole, (3) ciprofloxacin (5) and linezolid (6) in Figure 1 are fully synthetic 
drugs and, compared to the natural product derived antibiotics, lack in structural diversity and 
complexity. 
To overcome resistant pathogens, the discovery and development of new generations of antibiotics is 
greater than ever. Scientist from natural products isolation, total synthesis and medicinal chemists need 
to continue their efforts finding new targets and developing new classes of antibiotics. The synthesis of 
natural products on industrial scale is mostly achieved by semisynthesis. Isolation of the target or 
intermediates from nature or microbial fermentation reactors followed by synthetic modifications has 
allowed the development of highly complex drugs that could be produced at reasonable costs. Recent 
examples are the synthesis of artemisinin (10) from the fermentation product artemisinic acid (9) 
(Sanofi), trabectedin (12) from safracin B (11) (Pharma Mar) or paclitaxel (14) from 13, an isolate from 
European yew needles (Bristol-Myers Squibb) (Scheme 1).6 
 
 
Scheme 1 | Industrial semisynthesis of natural products. 
                                                     
5 a) J. M. Munita, C. A. Arias, A. R. Unit, A. D. Santiago, Microb. Spectr. 2016, 4, 1−37. b) J. M. A. Blair, M. A. Webber, A. 
J. Baylay, D. O. Ogbolu, L. J. V. Piddock, Nat. Rev. Microbiol. 2015, 13, 42−51. c) K. P. Langton, P. J. F. Henderson, R. B. 
Herbert, Nat. Prod. Rep. 2005, 22, 439−451. 
6 a) C. Cuevas et al., Org. Lett. 2000, 2, 2545−2548. b) C. Cuevas, M. Perez, A. Francesch, C. Fernandez, J. L. Chicharro, P. 
Gallego, M. Zarzuelo, F. de la Calle, I. Manzanares, International Patent WO 200069862, 2000. c) J. Turconi, F. Griolet, R. 
Guevel, G. Oddon, R. Villa, A. Geatti, M. Hvala, K. Rossen, R. Goeller, A. Burgard, Org. Process Res. Dev. 2014, 18, 417−422. 
d) J. Dhainaut, A. Dlubala, R. Guevel, A. Medard, G. Oddon, N. Raymond, J. Turconi, International Patent WO 2011026865, 
2011. e) R. A. Holton, International Patent WO 199306079, 1993. e) E. Ravina, The Evolution of Drug Discovery: From 
Traditional Medicines to Modern Drugs, Wiley-VCH: Weinheim, Germany, 2011. 
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Although semisynthetic methods increased over the last decades, there are cases were elaborated 
substructures or targets cannot be synthesized by this procedure and the remaining option becomes 
de novo total synthesis. Natural products that fit in that category forming the foundation of new 
antibiotic candidates are for example halichondrin B, epothilone, cryptophycin, PM060184, 
discodermolide, diazonamide A and ingenol. Those elaborated targets have attracted many synthetic 
chemistry groups over the last decades.7 
 
 
1.1.2 Strategies for the synthesis of cis-decalin systems 
The cis-decalin system is present in various natural products such as kalihinene X (15), nahuoic acid 
Ci(Bii) (16), ouabain (17), integramycin (18), coloradocin (19), branimycin (20) vinigrol (21) or 
stachyflin (22) (Figure 2). The interesting and synthetically challenging structure coupled with a vast of 
biological activities has led to the development of various new and efficient methods to access cis-
decalins.8 In this section, selected methods to synthesize cis-decalins by new methodologies or in natural 
product total synthesis are highlighted in a chronological order.9  
 
 
Figure 2 | Selected natural products featuring a cis-fused decalin system. 
 
                                                     
7 For a review see: T. K. Allred, F. Manoni, P. G. Harran, Chem. Rev. 2017, 117, 11994−12051. 
8 For a review see: V. Singh, S. R. Iyer, S. Pal, Tetrahedron 2005, 61, 9197–9231.  
9 For the synthesis of the aureol family of meroterpenoids see: K. Speck (2016) The Total Synthesis of Tetracyclic 
Meroterpenoid Natural Products – Gold(I)-Catalyzed Cyclizations of 1-Bromo-1,5-Enynes. PhD Thesis. LMU Munich. 
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One of the first examples for an asymmetric approach to cis-decalins was reported in 1989 by Shibasaki10 
in his asymmetric synthesis of 24 via an intramolecular Heck-type cyclization of alkenyl iodide 23 in 
the presence of a chiral ligand (Scheme 2a). 
 
 
Scheme 2 | Asymmetric approach towards cis-decalin 24 and 26 by a) Shibasaki and b) Guir. 
 
After extensive screening, cis-decalin 24 was obtained in 74% yield with an enantiomeric excess of 
46%. In 2003, the Guir laboratory further optimized this type of reaction utilizing triflate 25 as 
cyclization precursor.11 A wide range of phosphinamine ligands was screened for this reaction showing 
that palladium complexes formed with BINAP gave 26 (R = COOMe) in 65% yield and 83% ee. Other 
ligands like ferrocenyloxazoline gave the best results in terms of enantiomeric excess (85%) but low 
yields (30%) (Scheme 2b). 
 
 
Scheme 3 | Asymmetric synthesis of 28 by Shibasaki. 
 
Further developing their asymmetric synthesis of cis-decalin systems, the Shibasaki group reported 
another palladium catalyzed method from prochiral allylic acetate 27.12 Treatment of 27 with a complex 
of palladium(0) (generated from 1 equiv Pd(OAc)2 and 2 n-butyl lithium) and a chiral ligand in the 
presence of base induced the formation of an π-allyl palladium intermediate which then reacts with the 
                                                     
10 Y. Sato, M. Sodeoka, M. Shibasaki, J. Org. Chem. 1989, 54, 4738–4739. 
11 D. Kiely, P. J. Guir, Tetrahedron Lett. 2003, 44, 7377–7380. 
12 T. Takemoto, Y. Nishikimi, M. Sodeoka, M. Shibasaki, Tetrahedron Lett. 1992, 33, 3531–3532. 
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enolate to the highly substituted cis-decalin 28. After optimizing their methodology, 28 was obtained in 
34% and 83% ee (Scheme 3). This reaction was later applied in their total synthesis of (+)-vemolepin.13 
In 1996, the group of Liu reported a stereocontrolled synthesis of cis-decalin 32 and bicyclo[4.2.2]dec-
7-en-4-one 33.14 This methodology starts with tricycle 29, readily available via a two-step procedure 
from 2-methoxy phenol.15 Addition of vinylmagnesium bromide to 29 gave a diastereomeric mixture of 
alcohols 30 and 31 that were separated by column chromatography. Exposure of the minor 
diastereoisomer 30 to potassium hydride in the presence of 18-crown-six, initiated a [3,3]-sigmatropic 
rearrangement to afford 32. Under the same conditions, the major isomer 31 afforded an unexpected 
[1,3]-sigmatropic rearrangement product 33.  
 
 
Scheme 4 | Stereocontrolled syntheses of cis-decalin 32 and bicyclo[4.2.2]dec-7-en-4-one 33. 
 
A unique formation of cis-decalins from a linear precursor via a tandem Pauson–Khand cyclization was 
reported in 2000 by J. M. Cook and co-workers.16 Applying the Pauson–Khand protocol to diene-diyne 
34 afforded a mixture of cis:trans decalins (4:1) 35. To rationalize the preferential formation of the cis-
decalin system, MM2 calculations were performed to determine the relative energies of the 
diastereomers. Since calculations showed that the trans-decalin was slightly lower in energy than the 
cis-decalin (2.5 kcal/mol), steric interactions in the metallacycle intermediate during the Pauson–Khand 
reaction are expected to determine product formation in favor of the cis-decalin. Although the overall 
yield of 53% for the formation of 35 is just moderate, the yield of each individual carbon–carbon bond 
formed in this process was at least 89% (Scheme 5). 
 
 
Scheme 5 | A tandem Pauson–Khand reaction in the construction of tetracycle 35. 
 
                                                     
13 K. Ohrai, K. Kondo, M. Sodeoka, M. Shibasak, J. Am. Chem. Soc. 1994, 116, 11737–11748. 
14 T. Lee, C. Liao, W. Liu, Tetrahedron Lett. 1996, 37, 5897–5900. 
15 C. S. Chu, T. H. Lee, C. C. Liao, Synlett 1994, 635–636. 
16 S. G. Van Ornum, M. M. Bruendl, H. Cao, M. Reddy, D. S. Grubisha, D. W. Bennett, J. M. Cook, J. Org. Chem. 2000, 65, 
1957–1971. 
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Coloradocin (19), the most complex natural product of a family of polycyclic antibiotics has been 
targeted by the group of E. Gössinger (Scheme 6).17 Starting with 36, an intermediate from their former 
synthesis of nodusmicin,18 a six steps sequence gave access to fragmentation precursor 37. Treatment 
of 37 under mild acidic conditions induced fragmentation to a decalinone that is directly esterified to 
yield the cis-decalin core of 38 in good yield.  
 
 
Scheme 6 | Synthesis of the decalin subunit of coloradocin (19). 
 
The diterpenoid kalihinene X (41) belongs to a family of natural products possessing either a cis- or 
trans-decalin system connected to a tetrahydropyran or tetrahydrofuran unit. The first total synthesis of 
this natural product and determination of the absolute configuration was achieved by H. Mitome in 2002 
(Scheme 7).19 Oxidation of allylic alcohol 39, itself prepared in eight linear steps, with Dess–Martin 
periodinane resulted in the formation of a highly reactive exo-enone that directly underwent an 
intramolecular Diels–Alder cycloaddition, selectively forming cis-decalin 40. After this key step, the 
total synthesis of kalihinene X (41) was accomplished in six further steps.  
 
 
Scheme 7 | Total synthesis of marine diterpenoid kalihinene X (41). 
 
                                                     
17 E. Gössinger, A. Schwartz, N. Sereinig, Tetrahedron 2000, 56, 2007–2014. 
18 E. Gössinger, M. Graupe, K. Zimmermann, Monatsh. Chem. 1993, 124, 965–979. 
19 H. Miyaoka, H. Shida, N. Yamada, H. Mitome, Y. Yamada, Tetrahedron Lett. 2002, 43, 2227–2230. 
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During their development of a synthetic route towards ouabain (17), Jung and co-workers synthesized 
several novel hydroxylated cis-decalin derivatives containing the AB-ring system of the target (Scheme 
8).20 Protection of the carbonyl functionality in 42 under migration of the double bond gave alkene 43 
that was stereoselectively epoxidized to 44 with 3,3-dimethyldioxirane (DMDO) applying Yang’s 
protocol.21 Reductive opening of the epoxide with lithium aluminum hydride gave exclusively the 
desired AB ring system (highlighted in orange) of ouabain (17). 
 
 
Scheme 8 | Synthetic approach to the AB ring system of ouabain (17). 
 
In 2005, the group of W. R. Roush accomplished the synthesis of the core fragment 47 of integramycin 
(18) (Scheme 9).22 Biosynthetically, the decalin core of integramycin (18) might arise via an exo-
selective, intramolecular type I Diels–Alder reaction. Since this would proceed via a sterically 
disfavored transition state, the group of Roush developed a suitable cyclization precursor for this 
reaction. First, (E)-46 was synthesized and the intramolecular Diels–Alder reaction was initiated by 
treatment with methylaluminum dichloride. Contrary to expectations, this resulted selectively in the 
formation of the trans-fused decalin. To investigate the influence of the double bond geometry, triene 
(Z)-46 was synthesized accordingly. When this cyclization precursor was treated with methylaluminum 
dichloride at –78 °C, cis-fused decalin 47 was formed in 92% yield. Those type of reactions are 
hypothesized to proceed via a concerted but nonsynchronous transition state. Therefore, bonding 
between C-1 and C-10 are more advanced than the bonding between C-4 and C-9 and by minimizing 
steric repulsion of the diene and the dieneophile, the cis vs. trans ring fusion selectivity is inverted (i.e. 
(E)-46 leads to the trans- and (Z)-46 leads to the cis-decalin).23 
 
                                                     
20 M. E. Jung, G. Piizzi, J. Org. Chem. 2003, 68, 2572–2582. 
21 D. Yang, G.-S. Jiao, Chem. Eur. J. 2000, 6, 3517–3521. 
22 T. A. Dineen, W. R. Roush, Org. Lett. 2005, 7, 1355–1358. 
23 W. R. Roush, S. M. Peseckis, J. Am. Chem. Soc. 1981, 103, 6–12. 
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Scheme 9 | A Diels–Alder approach to the core unit 47 of integramycin (18). 
 
In 2005, the group of Jin and coworkers reported a convergent strategy for the asymmetric synthesis of 
the decalin core of the macrolide superstolide A (48) (Scheme 10a).24 Their synthesis of the cis-decalin 
commenced with a double Michael addition sequence between lithium-enolate of 49 and 50 giving just 
one of eight possible diastereomers. The so obtained tricycle 51 was further converted into 52 in eight 
steps. The cis-decalin system 53 was formed via an anionic oxy-Cope rearrangement of 52 initiated by 
an excess of potassium bis(trimethylsilyl)amide at elevated temperature. 
Six years later, the Jin laboratory reported a new, powerful approach to the cis-decalin core of 
superstolide A (48) (Scheme 10b).25 They investigated a regio, stereo, and facial selective [4+2] 
cycloaddition between an 1,3-diene with highly activated vinyl sulfones. This new methodology has 
been applied to access bicyclo[2.2.2]octanone 56 by the reaction of diene 54 and dienophile 55 in 
excellent yield. The cyclization product was further converted into 57 which underwent an anionic oxy-
Cope rearrangement to afford cis-decalin 58. With those two approaches towards the total synthesis of 
superstolide A (48), Jin and coworkers had set the foundation for the total synthesis of truncated 
superstolide A. 26 
 
                                                     
24 Z. Hua, W. Yu, M. Su, Z. Jin, Org. Lett. 2005, 7, 1939–1942. 
25 L. Chen, Z. Hua, G. Li, Z. Jin, Org. Lett. 2011, 13, 3580–3583. 
26 L. Chen, K. B. Riaz A., P. Huang, Z. Jin, Angew. Chem. Int. Ed. 2013, 52, 3446–344. 
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Scheme 10 | Construction of the cis-declain systems a) 53 and b) 59 via an anionic oxy-Cope rearrangement. 
 
In 1998, branimycin (20) was isolated by the Laatsch group from the actinomycetes strain GW 
60/1571.27 Due to its promising antibiotic activity against Streptomyces viridochromogenes, the Mulzer 
group from the university of Vienna became interested in this complex natural product.28 In their first 
approach, the cis-decalin system was planned be formed by a transannular Diels–Alder reaction 
(TADA). Based on previous results from the Roush group29 and supported by DFT calculations, Mulzer 
and coworkers designed cyclization precursor 60 that should undergo a TADA reaction via the exo 
transition state. Indeed, the TADA reaction could be initiated by refluxing 60 in xylene for 36 h and the 
                                                     
27 M. Speitling, Dissertation, Universität Gçttingen (Germany), 1998. 
28 For the full paper of all approaches perused see: V. S. Enev, W. Felzmann, A. Gromov, S. Marchart, J. Mulzer, Chem. Eur. 
J. 2012, 18, 9651–9668. 
29 a) W. R. Roush, J. W. Coe, Tetrahedron Lett. 1987, 28, 931–934. b) J. W. Coe, W. R. Roush, J. Org. Chem. 1989, 54, 915–
930. 
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desired product 61 was obtained in 80% yield (Scheme 11a).30 At this stage, this route was abandoned 
due to more promising results in their group.  
In their second approach, an intramolecular nitrile oxide olefin (INOC) cyclization reaction was applied 
to form the cis-decalin core.31 This strategy was first tested on a model substrate 62 that was stable 
towards double bond isomerization. Formation of the nitrile oxide was followed by in situ cycloaddition 
to yield isoxazoline 63 as a single diastereomer (Scheme 11b).32 This promising results were then 
translated to a suitable substrate for the total synthesis of branimycin (20). Unfortunately, this substrate 
was prone to epimerization and the approach was completely discarded.  
Another approach started from (–)-quinic acid as cheap (0.98 €/g) chiral building block from which 
intermediate 64 was synthesized in 17 steps (Scheme 11c).33 By forming the TMS-enolether in situ, the 
Claisen–Ireland rearrangement was initiated giving 65 as a mixture of diastereomers for the OBn group. 
Olefin 65 was further functionalized by esterification, reduction to the aldehyde and Wittig reaction to 
the ring-closing metathesis precursor 66. In the course of screening for the optimal conditions, Hoveyda–
Grubbs’ second generation catalyst gave the desired product 67 in 65% yield. In the following four steps, 
highly functionalized cis-α,β-unsaturated ketone 68 was prepared with all positions functionalized for 
the synthesis of branimycin (20). However, 64 has to be synthesized in a 17 steps sequence and 
stereocenter at C-1 has to be inverted at some later stage.  
Hence, a more direct route still employing a ring-closing metathesis reaction to form one of the decalin 
rings was developed.34 In a nine steps desymmetrization sequence, 69 was transformed into 70 
employing an enzymatic, enantiotopos-selective acetylation.35 The side chain containing the second 
double bond for the ring-closing metathesis reaction was introducted by intermolecular Hiyama–
Nozaki–Kishi reaction of aldehyde 70 with allylbromide 71. In the presence of chromium(II) chloride, 
a mixture of three diastereomeric alcohols 72 was obtained (only the desired diastereomers are shown 
in Scheme 11d). After oxidation of the secondary alcohol 72 with Dess–Martin periodinane and 
epoxidation with meta-chloroperoxybenzoic acid, 73 was subjected to ring-closing metathesis 
conditions giving 74 that was further converted into a highly elaborated intermediate. Those results 
encouraged the Mulzer group to develop a shorter route to access a decalin intermediate 79 by 
desymmetrization of diepoxynaphthalene 78.36 Starting with a twofold Diels–Alder reaction of methyl 
propiolate (76) and furan (75), cis-decalin 77 was generated in multigram quantities. Formal 
decarboxylation of 77 proceeded uneventfully and diepoxynaphthalene 78 was obtained in good overall 
                                                     
30 J. Mulzer, D. Castagnolo, W. Felzmann, S. Marchart, C. Pilger, V. S. Enev Chem. Eur. J. 2006, 12, 5992–6001. 
31 For a review see: J. Mulzer in Organic Synthesis Highlights, Vol. I (Eds.: J. Mulzer, H. J. Altenbach, M. Braun, K. Krohn, 
H. U. Reissig), VCH, Weinheim, 1990, 77. 
32 V. S. Enev, M. Drescher, J. Mulzer, Tetrahedron 2007, 63, 5930–5939. 
33 S. Marchart, J. Mulzer, V. S. Enev, Org. Lett. 2007, 9, 813–816. 
34 V. S. Enev, M. Drescher, J. Mulzer, Org. Lett. 2008, 10, 413–416. 
35 For the first four steps see: a) C. Cinquin, I. Shaper, G. Mandville, R. Bloch, Synlett, 339–340. b) K. Takao, H. Yasui, S. 
Yamamoto, D. Sasaki, S. Kawasaki, G. Watanabe, K. Tadano, J. Org. Chem. 2004, 69, 8789–8795. 
36 A. Gromov, V. Enev, J. Mulzer, Org. Lett. 2009, 11, 2884–2886. 
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yield (Scheme 11e). Synthesis of intermediate 79 was then accomplished by desymmetrization of 78 via 
two successive SN2’ reactions and the total synthesis of branimycin (20) was accomplished.37 
 
Scheme 11 | Novel Approaches to highly substituted cis-decalin systems. 
                                                     
37 S. Marchart, A. Gromov, J. Mulzer, Angew. Chem. Int. Ed. 2010, 49, 2050–2053. 
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In 2008, Danishefsky reported a convergent, stereocontrolled synthesis of the cell adhesion inhibitor 
peribysin E (84) from carvone (80).38 Retrosynthetically, the cis-fused six-five carbon skeleton of 
peribysin E (84) should be available from a cis-decalin system. In this context, enone 83 was envisioned 
as suitable intermediate. Its synthesis commenced with a Diels–Alder cycloaddition between 
commercially available dienophile carvone (80) and the diene 81. The iso-prenyl residue of 80 should 
direct the stereofacial sense of this reaction. As predicted, Lewis acid promoted Diels–Alder reaction 
between 80 and 81 gave selectively the cis-decalin 82 that was directly subjected to Saegusa oxidation 
affording enone 83 in good overall yield. With this intermediate in hand, Danishefsky and coworker 
finished the total synthesis of peribysin E (84) in 15 further steps (Scheme 12).  
 
 
Scheme 12 | Total synthesis of peribysin E (84). 
 
The marine natural product popolohuanone E is believed to be derived by oxidative dimerization of 6′-
hydroxyarenarol (87). To verify this hypothesis, the group of Anderson targeted 87 by total synthesis in 
2008.39 One of their key transformations was the Lewis acid promoted Hosomi–Sakurai reaction of 85 
in the presence of chloromethyl methyl sulfide forming cis-decalin 86 as a single diastereomer. The 
target molecule 87 was obtained after eight steps, but the envisioned dimerization proved to be more 
challenging than anticipated.  
 
 
Scheme 13 | Synthesis of 6′-hydroxyarenarol (87). 
 
                                                     
38 A. R. Angeles, S. P. Waters, S. J. Danishefsky, J. Am. Chem. Soc. 2008, 130, 13765–13770. 
39 R. H. Munday, R. M. Denton, J. C. Anderson, J. Org. Chem. 2008, 73, 8033–8038. 
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In their course of synthesizing the natural products eremophilenolide (97), eremophiledinone (96) and 
deoxyeremopetasidione (95), the Das laboratory developed a new and efficient route to construct their 
common structural feature, a cis-fused decalin system.40 Starting with a highly stereoselective, Lewis 
acid mediated Diels–Alder cycloaddition between diene 88 and commercially available tiglic aldehyde 
(89), olefin 90 was obtained in very good yield. After five steps, the precursor 91 (or 92) for the second 
key transformation was obtained. By treating 91 (or 92) with aqueous hydrochloric acid (6 M), an 
intramolecular aldol condensation was initiated forming the cis-fused decalin system 93 (or 94). With 
those two building blocks in hand, the target natural products 95–97 were successfully synthesized 
(Scheme 14).  
 
 
Scheme 14 | A new route to eremophilanes: synthesis of eremophilenolide (97), eremophiledinone (96) and 
deoxyeremopetasidione (95). 
 
For the first total synthesis of the cardioactive glycoside ouabain (17), isolated from the bark of the 
African ouabio tree (Acokanthera ouabio) by Arnaud 1888,41 the group of Deslongchamps applied an 
earlier developed methodology for steroid synthesis.42 The construction of cis-decalin 100 was realized 
by anionic polycyclization of freshly prepared 99 with substituted Nazarov reagent 98 promoted by 
cesium carbonate. From 100, the total synthesis of ouabain (17) was accomplished in 18 steps (Scheme 
15).43 
 
                                                     
40 P. Srinivas, D. S. Reddy, K. S. Kumar, P. K. Dubey, J. Iqbal, P. Das, Tetrahedron Lett. 2008, 49, 6084–6086. 
41 a) L. F. Fieser, M. Fieser, Steroids, Reinhold, New York, 1959, chap. 20. b) A. Arnaud, C. R. Hebd. Seances Acad. Sci. 1888, 
106, 1011. c) A. Arnaud, C. R. Hebd. Seances Acad. Sci. 1888, 107, 1162. 
42 a) R. Ruel, P. Deslongchamps, Tetrahedron Lett. 1990, 31, 3961–3964. b) R. Ruel, P. Deslongchamps, Can. J. Chem. 1992, 
70, 1939–1949. 
43 H. Zhang, M. S. Reddy, S. Phoenix, P. Deslongchamps, Angew. Chem. Int. Ed. 2008, 47, 1272–1275. 
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Scheme 15 | Total synthesis of ouabain (17). 
 
The diterpene vinigrol (21) was isolated 1987 by Hashimoto and co-workers from the fungal strain 
Virgaria nigra F-5408.44 The interesting biological activities combined with a highly complex carbon 
skeleton has attracted numerous synthetic chemists in the last decade.45 Based on previous results from 
the Paquette group that showed the difficulties in the formation of the eight membered ring from an pre-
existing cis-decalin system, Baran and coworkers reported the first total synthesis of vinigrol (21) in 
2009 (Scheme 16a).46 The synthesis started with an endo-selective Diels–Alder reaction between diene 
101 and dienophile 102 affording bicyclic ketone 103. In the following two steps the vinyl group was 
introduced by triflation and Stille cross-coupling. After formal reduction of the ester to the aldehyde, 
allyl magnesium bromide was added forming intermediary alkoxide 105. Direct heating of 105 to 105 °C 
initiated an intramolecular Diels–Alder reaction to provide 106. With this key intermediate in hand, 
vinigrol (21) was finished in 13 steps (Scheme 16a). 
A similar strategy for the construction of the decalin core was utilized by Barriault in his formal synthesis 
of vinigrol (21).47 Instead of forming the Diels–Alder cyclization precursor in situ, 108 was synthesized 
and treated with thin(IV) chloride at –78 °C to provide the desired vinigrol-core 109 via an 
intramolecular Diels–Alder reaction.  
In the same year, Li published an unprecedented approach to vinigrol (21).48 The first part of the vinigrol 
scaffold 111 was synthesized via an one-pot oxidative dearomatization/Diels–Alder reaction of 
cyclization precursor 110. After the second step, a tandem 6-exo-trig Heck cyclization, the complete 
carbon skeleton 112 was formed and the synthesis of vinigrol (21) was completed in 27 linear steps.  
 
                                                     
44 I. Uchida, T. Ando, N. Fukami, K. Yoshida, M. Hashimoto, T. Tada, S. Koda, Y. Morimoto, J. Org. Chem. 1987, 52, 5292–
5293. 
45 For a review see: C. Draghici, J. T. Njardarson, Tetrahedron 2015, 71, 3775–3793. 
46 a) T. J. Maimone, A. Voica, P. S. Baran, Angew. Chem. Int. Ed. 2008, 47, 3054–3056. b) T. J. Maimone, J. Shi, S. Ashida, 
P. S. Baran, J. Am. Chem. Soc. 2009, 131, 17066–17067. 
47 a) L. Morency, L. Barriault, Tetrahedron Lett. 2004, 45, 6105–6107. b) J. Poulin, C. M. Grisé-Bard, L. Barriault, Angew. 
Chem. Int. Ed. 2012, 51, 2111–2114. 
48 Q. Yang, J. T. Njardarson, C. Draghici, F. Li, Angew. Chem. Int. Ed. 2013, 52, 8648–8651. 
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Scheme 16 | Total syntheses of the cis-decalin core of vinigrol (21). 
 
In their retrosynthetic analysis of lyconadin A (115), the group of Fukuyama proposed the synthesis of 
the cis-six-seven system via a ring expansion of cis-decalin system 114.49 The first task in their synthetic 
route was the construction the cis-decalin system 114 via a Diels–Alder cycloaddition between 113 and 
isoprene (116) applying Overman’s conditions.50 From this building block, lyconadin A (115) was 
successfully synthesized in ten further steps (Scheme 17). 
 
                                                     
49 T. Nishimura, A. K. Unni, S. Yokoshima, T. Fukuyama, J. Am. Chem. Soc. 2011, 133, 418–419. 
50 a) B. L. Nilsson, L. E. Overman, J. Read de Alaniz, J. M. Rohde, J. Am. Chem. Soc. 2008, 130, 11297–11299. b) R. A. 
Altman, B. L. Nilsson, L. E. Overman, J. Read de Alaniz, J. M. Rohde, V. Taupin, J. Org. Chem. 2010, 75, 7519–7534. 
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Scheme 17 | Total synthesis of lyconadin A (115). 
 
In 2012, the Lee group reported a concise, enantioselective total synthesis of teucvidin (120).51 In this 
synthesis their recently reported methodology to construct cis-fused decalin systems via an amine-
induced Michael/Conia-ene cascade cyclization was implemented.52 Starting from enantiomerically 
enriched 117, (E:Z 1:1) extensive screening revealed the optimal combination of transition metal salts, 
amine base and solvent. Treatment of 117 with zinc(II) triflate and diethylamine in 1,2-dichloroethane 
initiated the formation of kinetic Michael adduct 118. Then, indium(III) triflate and molecular sieves 
were added and the second part of the cascade reaction, the Conia-ene reaction occurred to afford cis-
decalin 119 which could be transformed into teucvidin (120) in a 12 step sequence.  
 
 
Scheme 18 | Total synthesis of teucvidin (120). 
 
In 2013, the Shoji laboratory reported an efficient methodology to access cis-decalin systems via a 
stereoselective domino cyclization cascade enabling the synthesis of polycyclic steroids with a wide 
variety of functional groups.53  
 
 
Scheme 19 | Stereoselective construction of cis-decalin framework 122 and 123 via radical domino cyclization. 
                                                     
51 X. Liu, C. Lee, Org. Lett. 2012, 14, 2886–2889. 
52 W. Li, X. Liu, X. Zhou, C. Lee, Org. Lett. 2010, 12, 548–551. 
53 E. Suzuki, M. Ueda, S. Ohba, T. Sugai, M. Shoji, Tetrahedron Lett. 2013, 54, 1589–1592. 
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Initial exposure of cyclization precursor 121 to manganese(III) acetate and copper(II) acetate in acetic 
acid at 50 °C gave a mixture of cis-and trans-fused decalin systems. After intensive optimizations, the 
combination of manganese(III) acetate and copper(II) triflate in the presence of triflic acid afforded 
predominately (cis:trans 4.7:1) the desired cis-decalin 122 (and 123) (Scheme 19). 
For the synthesis of various terpenic structures, bioinspired radical cyclizations have proved to be a 
powerful methodology.54 In this context, the Cuerva group developed a titanium(III)-catalyzed radical 
cyclization of epoxypolyprenes (such as 124) with an internal keto functionality.55 The enol radical 125 
should be trapped by a highly oxophilic titanium radical (Cp2ClTi•) terminating the cyclization cascade. 
After acidic workup, the cyclization product, ketone 127 can be isolated (Scheme 20a). With this 
methodology, the final number of rings formed in this cascade reaction depends on the position of the 
keto group in the cyclization precursor and is not determined by the number of prenyl subunits. To 
investigate the scope of their methodology, numerous ketoepoxypolyprenes (128) were treated with 
substoichiometric amounts of Cp2TiCl2 in combination with Me3SiCl, 2,4,6-collidine and manganese. 
Interestingly, all conditions tested lead to the formation of 129–133 with a cis-fused decalin system 
(Scheme 20b). This unexpected chemo- and stereoselectivity was elucidated by DFT calculations. Those 
calculations revealed that the carbonyl group in the cyclization precursor plays an important role in two 
processes: (1) Stabilization of the formed radical and reaction with oxophilic titanium species and (2) 
the corresponding side chain is forced by either template or conformational effects to follow a pathway 
that forms the cis-decalin system.  
 
Scheme 20 | Ti(III)-Catalyzed cyclizations of ketoepoxypolyprenes. 
 
In 2017, Smith reported a convergent total synthesis of the recently isolated natural product nahuoic 
acid Ci(Bii) (16).56 All members of the nahuoic acid family feature a highly substituted cis-declain core. 
From a synthetic point of view, the first task was the formation of the decalin core 136 followed by the 
                                                     
54 For a review see: J. Justicia, L. Álvarez de Cienfuegos, A. G. Campana, D. Miguel, V. Jakoby, A. Gansaüer, J. M. Cuerva, 
Chem. Soc. Rev. 2011, 40, 3525−3537. 
55 S. P. Morcillo, D. Miguel, S. Resa, A. Martín-Lasanta, A. Millán, D. Choquesillo-Lazarte, J. M. García-Ruiz, A. J. Mota, J. 
Justicia, J. M. Cuerva, J. Am. Chem. Soc. 2014, 136, 6943−6951. 
56 Q. Liu, Y. Deng, A. B. Smith, J. Am. Chem. Soc. 2017, 139, 13668−13671. 
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final decoration. For the synthesis of the requisite cis-decalin 136, Smith explored a Lewis acid 
mediated, asymmetric Diels–Alder reaction (Scheme 21). Probing the chemo- and regioselectivity of 
this reaction, cycloaddition between 134 and 135 was carried out under thermal conditions giving the 
desired isomer (±)-136.  
 
 
Scheme 21 | Total synthesis of nahuoic acid Ci(Bii) (137). 
 
Encouraged by this results, the reaction was optimized in terms of Lewis acid, ligand, solvent and 
temperature. In the end, the cycloaddition catalyzed by chiral titanium complex 137 gave cis-decalin 
136 in 95% yield with 86% ee. With 136 in hand, Smith and coworker were able to synthesize nahuoic 
acid Ci(Bii) (16) after 14 steps. 
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1.1.3 Methods overview 
Table 1 | Overview of methods for the synthesis of cis-fused decalins. 
Palladium catalyzed cross coupling 
 
Oxy-Cope rearrangement 
 
Pauon–Khand reaction 
 
Intramolecular Diels–Alder 
 
Intermolecular Diels–Alder 
 
Intramolecular nitrile oxide olefin (INOC)  
 
Ring-closing metathesis 
 
Hosomi–Sakurai reaction 
 
Michael/Conia-ene cascade cyclization 
 
Radical domino cyclization 
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1.2 Results and Discussion 
1.2.1 Gold(I)-Catalyzed Enyne Cyclizations: Studies Towards the 
Total Synthesis of (+)-Aureol 
 
 
 
Reprinted with permission from: 
R. Wildermuth, K. Speck, T. Magauer, Synthesis, 2016, 48, 1814–1824. 
Copyright © 2016 Georg Thieme Verlag KG 
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1.2.2 A Modular Synthesis of Tetracyclic Meroterpenoid 
Antibiotics 
 
 
 
Reprinted with permission from: 
R. Wildermuth, K. Speck, F.-L. Haut, P. Mayer, B. Karge, M. Brönstrup, T. Magauer, Nat. Commun. 
2017, 8, 2083. 
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. 
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1.3 Conclusion and Outlook 
 
In Part I of this thesis, a general entry to the aureol family of meroterpenoid natural products was 
developed, which cumulated in the total synthesis of stachyflin, aureol, smenoqualone, strongylin A, 
cyclosmenospongine and mamanuthaquinone. The route employs an auxiliary-controlled Diels–Alder 
reaction to enable the enantioselective construction of the decalin subunit, which is connected to 
variously substituted arenes by either carbonyl addition chemistry or sterically demanding sp2–sp3 cross-
coupling reactions and an acid mediated cyclization to selectively generate either stereoisomer of the 
decalin subunit. Simultaneous structural variation of more than one coupling component leads to rapid 
expansion of the compound library and 15 non-natural derivatives were obtained.  
The library of natural and fully synthetic molecules obtained so far was screened against a panel of 
bacterial pathogens and mammalian cell lines in collaboration with the group of Prof. Dr. Mark 
Brönstrup (Helmholtz Centre for Infection, Braunschweig). Notably, the pronounced antibiotic activity 
of a non-natural derivative, (+)-strongylin A and (+)-aureol against methicillin-resistant Staphylococcus 
aureus in the low M range appears promising. The reported SAR suggests that a further enhancement 
to activity is possible, e.g. through modifications at the aromatic ring, and such modifications enabled 
by the described synthetic platform. 
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2.1 Introduction 
2.1.1 The nonadride family 
2.1.1.1 Isolation and biological activity 
The natural products glauconic acid (138), glaucanic acid (139), byssochlamic acid (140),57 rubratoxin 
A (141), B (142) and C (143),58 scytalidin (144),59 desoxyscytalidin (145),60 heveadride (146),61 
homoheveadride (147),62 cornexistin (148),63 hydroxycornexistin (149)64 and phomoidrides A (150), B 
(151),65 C (152) and D (153)66 isolated and characterized over the last century from various fungal 
sources (Figure 3) belong to the nonadride family. Homoheveadride (147) is the only nonadride isolated 
from lichen (cladonia polycarpoides). The terminus “nonadride“ was introduced in 1962 and first 
described a family of natural products that was biosynthetically derived from dimerization of two C9-
building blocks.67 Later, the term evolved and now includes compounds that possess the core structure 
of nonandrides (highlighted in blue), a nine-membered carbocycle fused to one or two maleic anhydride 
units whereas cornexistin (148) and hydroxycornexistin (149) are the only congeners that feature just 
one maleic anhydride moiety. To date, the fungal metabolites phomoidrides A (150), B (151), C (152) 
and D (153) are the most complex members of the nonadride family and feature a bicyclo[4.3.1]deca-
1,6-diene framework, sharing the same biosynthetical pathway as the other congeners.68 From a 
structural point, one major difference from other members of the nonadride family is the geometry of 
the double bond embedded in the nine-membered carbocycle highly increasing the structural complexity 
of those natural products.  
 
                                                     
57 For 138, 139 and 140: a) N. Wijkman, Liebigs Ann. 1931, 485, 61–73. b) J. E. Baldwin, D. H. R. Barton, J. L. Bloomer, L. 
M. Jackman, L. Rodriguez-Hahn, J. K. Sutherland, Experientia 1962, 18, 345–352. c) H. Raistrick, G. Smith, Biochem. J. 1933, 
27, 1814–1819. d) D. H. R. Barton, J. K. Sutherland, J Sulikowski–1772. e) D. H. R. Barton, L. M. Jackman, L. Rodriguez-
Hahn, J. K. Sutherland, J. Chem. Soc. 1965, 1772–1778. f) D. H. Barton, L. D. S. Godinho, J. K. Sutherland, J. Chem. Soc. 
1965, 1779–1786. g) T. A. Hamor, I. C. Paul, J. M. Robertson, G. A. Sim, Experientia 1962, 18, 352–354. 
58 a) R. J. Townsend, M. Moss, H. M. Peck, J. Pharm. Pharmacol. 1966, 18, 471–473. b) M. O. Moss, A. B. Wood, F. V. 
Robinson, Tetrahedron Lett. 1969, 10, 367–370. c) M. O. Moss, F. V. Robinson, A. B. Wood, H. M Paisley, J. Feeney, Nature 
1968, 220, 767–770. d) G. Buechi, K. M. Snader, White, J. Z. Gougoutas, S. Singh, J. Am. Chem. Soc. 1970, 92, 6638–6641. 
e) R. Chen, Z. Yan, J. Zou, N. Wang, J. Da, Chinese Chem. Lett. 2014, 25, 1308–1310. 
59 a) G. M. Strunz, M. Kakushima, M. A. Stillwell, J. Chem. Soc., Perkin Trans. 1 1972, 2280–2283. b) M. A. Stillwell, R. E. 
Wall, G. M. Strunz, Can. J. Microbiol. 1973, 19, 597–602. 
60 W. A. Ayer, P. Lu, H. Orszanska, L. Sigler, J. Nat. Prod. 1993, 56, 1835–1838. 
61 R. I. Crane, P. Hedden, J. MacMillan, W. B. Turner, J. Chem. Soc., Perkin Trans. 1 1973, 194–200. 
62 A. W. Archer, W. C. Taylor, Phytochemistry 1987, 26, 2117–2119. 
63 a) T. Haneishi, M. Nakajima, K. Koi, K. Furuya, S. Iwado, S. Sato, EP 0 290 113 1988. b) M Nakajima, K. Itoi, Y. Takamatsu, 
S. Sato, Y Furukawa, K. Furuya, T. Honma, J. Kadotani, M. Kozasa, T. J. Haneishi, J. Antibiot. 1991, 44, 1965–1972. 
64 S. C. Fields, L. Mireles-Lo, B. C. Gerwick, J. Nat. Prod. 1996, 59, 698–700. 
65 For 150 and 151: a) T. T. Dabrah, H. J. Harwood, L. H. Huang, N. D. Jankovich, T. Kaneko, J. C. Li, S. Lindsey, P. M. 
Moshier , T. A.Subashi, M. Therrien, P. C. Watts, J. Antibiot. 1997, 50, 1–7. b) T. T. Dabrah, T. Kaneko, W. Massefski, E. B. 
Whipple, J. Am. Chem. Soc. 1997, 119, 1594–1598. 
66 P. Spencer, F. Agnelli, G. A. Sulikowski, Org. Lett. 2001, 3, 1443–1445. 
67 For a review see: a) X. Chen, Y. Zheng, Y. Shen, Chem. Rev. 2007, 107, 1777−1830. b) D. A. Spiegel, J. T. Njardarson,I. 
M. McDonald, J. L. Wood, Chem. Rev. 2003, 103, 2691–2727. 
68 G. A. Sulikowski, F. Agnelli, R. M. Corbett, J. Org. Chem. 2000, 65, 337–342. 
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Figure 3 | Members of the nonadride family of natural products. 
 
All members of this family show various biological activities whereas cornexistin (148) and 
hydrocornexistin (149) show outstanding post-emergence herbicidal activity against monocotyledonous 
plants that grow in association with corn.63,64 Compared to commercially available herbicides like 
glyphosate or bialaphos, 148 shows the same or greater herbicidal activity. Additionally, cornexistin 
(148) shows herbicidal effects against dicotyledonous plants but with non-selective killing effects. Corn 
seeds were able to tolerate cornexistin making it a non-selective, broad spectrum herbicide with 
selectivity to corn (Figure 4). This effect was experimentally visualized by treatment of a sample 
containing corn and nine different weeds was treated with cornexistin (0.5 kg/ha). After 25 weeks, the 
control sample shows corn growing in association with weeds. The sample on the right was sprayed 
with cornexistin on day nine and shows excellent growth inhibition of annual weeds. Additionally, 
cornexistin showed no activity against gram-positive and negative bacteria and fungi (1 mg/mL) and 
low toxicity in mice (LD50 > 1 g/kg (o.p.); 100 mg/kg (i.p.)). 
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Figure 4 | Selective herbicidal activity of cornexistin (148): a) control; b) treated with cornexistin. 
 
 
2.1.1.2 Biosynthesis 
In 1965, a biosynthesis for byssochlamic acid (140), heveadride (146) and glaucanic acid (139) was 
postulated by Barton and Sutherland.57c This hypothesis was verified in 2016 for the biosynthetic 
pathway to byssochlamic acid (140) through genome and transcriptome sequencing, gene disruption, 
and heterologous expression by R. J. Cox.69 Based on these results, a general biosynthetic pathway to 
nonadrides was postulated (Scheme 22). Catalyzed by the citrate-synthase-like enzyme oxaloacetate 
(155) is reacted with a polyketide building block 154 (chain length and pattern of reduction can vary for 
different natural products) which is either released as the free acid (X = OH) or the CoA-thioester 
(X = SCoA) from the PKS by the BfL1 hydrolase. In the following step, dehydration by the 
methylcitrate dehydratase homologue gives 156 and its decarboxylated homologs 157 and 158. KI-like 
enzymes can now dimerize 156 with either 157 or 158 in a head-to-tail or a head-to-head fashion to form 
byssochlamic acid type, glauconic acid type and heveadride type nonadrides. 
 
                                                     
69 K. Williams, A. J. Szwalbe, N. P. Mulholland, J. L. Vincent, A. M. Bailey, C. L. Willis, T. J. Simpson, R. J. Cox, Angew. 
Chem. Int. Ed. 2016, 55, 6784–6788. 
a) Control b) Cornexistin 0.5 kg/ha 
+ Gramin-S 0.1% 
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Scheme 22 | Proposed biosynthetic pathway to nonandrides 140, 138 and 146 adopted by R. J. Cox.69 
 
In 2000, the group of Sulikowski outlined a biosynthesis for the highly complex nonadrides 
phomoidrides A (150), B (151).68,70 For the dimerization of 159 it is believed that both reaction partners 
have to be covalently attached (analog to polyketide and fatty acid biosynthesis via thioester bonds) to 
an enzyme active site. It is hypothesized that the dimerization proceeds in a stepwise fashion as a series 
of two Michael additions followed by an transannular Dieckmann condensation resulting in the carbon 
skeleton 160. After the final steps featuring hydrolysis, decarboxylation, and oxidation 150 is obtained.  
 
                                                     
70 T. T. Dabrah, T. Kaneko, W. Massefski, E. B. Whipple, J. Am. Chem. Soc. 1997, 119, 1594–1598. 
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Scheme 23 | Proposed biosyntheses of 150. 
 
In 2017, the group of R. J. Cox elucidated the biosynthetic pathway of cornexistin (148) in in vitro 
experiments with fungus P. variotii (Scheme 24). Since a very low titre of byssochlamic acid (140) was 
observed in this fungal system, 140 was expected to be an intermediate of the biosynthetic pathway of 
cornexistin (148). However, this hypothesis could not be verified by feeding experiments. If 140 was 
fed to the maleidride PKS KO strain of P. variotii, no synthesis of cornexistin (148) was observed. This 
shows, that 140 is not able to penetrate the cell membrane or is unable to access the compartment where 
biosynthesis occurs. A biosynthetic key step includes the oxidative removal of one of the maleic 
anhydride unit in 140 to give 161. The group of R. J. Cox was able to show that proteins encoded by 
pvL7, pvL9, pvL11 and pvL14 are involved in this step.  
 
 
Scheme 24 | Proposed biosynthesis of cornexistin (148) adopted from R. J. Cox. 
 
The nine-membered carbocycle is now decorated by oxygenases encoded by pvL5 and pvL13. Selective 
hydroxylation at C-6 position followed by hydroxylation at C-2 should lead to intermediate 163. 
However, only the respective hemiacetal 164 could be isolated and characterized. To date, the exact 
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mechanism of the last step from 164 to 148 is not fully elucidated. It is assumed, that the elimination 
can be catalyzed by pvL13 encoded multifunctional cytochrome P450 oxidases. 
 
 
2.1.2 Literature Syntheses 
2.1.2.1 Byssochlamic acid  
In 1972, the group of Stork accomplished the total synthesis of byssochlamic acid (140) being the first 
total synthesis of a nonadride natural product.71 Ketone 165 and 2,3-dichloromethyl- 1,4-
dimethoxybenzene (166) were coupled in a double alkylation sequence under basic conditions in 
excellent yield. Formation of the nine-membered carbocycle 168 was achieved by transforming 167 into 
the oxime (no conditions are reported) followed by fragmentation with phosphorus oxychloride in 
pyridine. 1,2-addition of methyllithium and subsequent Wolff–Kishner reduction of the resulting imine 
gave access to 169.  
 
 
Scheme 25 | First racemic total synthesis of byssochlamic acid (140) by Stork. 
 
Due to sterical hindrance, catalytic hydrogenation of the double bond was unsuccessful to access 170. 
However, Birch reduction lead to the formation of a single product which was later characterized as the 
desired isomer 170 by single crystal X-ray structure analysis. Next, the substituted benzene rings had to 
be converted into maleic anhydride moieties. This was accomplished by initial cleavage of the methyl 
                                                     
71 G. Stork, J. M. Tabak, J. F. Blount, J. Am. Chem. Soc. 1972, 94, 4735–4737. 
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ether with boron tribromide. The resulting unstable hydroquinone was directly oxidized with potassium 
permanganate followed by treatment with lead tetraacetate in acetic acid to give byssochlamic acid 
(140). 
The White group demonstrated the applicability of a [2+2]-photoaddition/cycloreversion strategy for 
the synthesis of nine-membered carbocycles in their asymmetric total synthesis of (+)-byssochlamic 
acid (140).72 Irradiation of a 1:1 mixture of diastereomers of dilactone 171 resulted in a [2+2]-
cycloaddition and formation of the two stereoisomeric photoadducts 172 and 173 (1:1 mixture) (Scheme 
26). Thermally induced cycloreversion led to cleavage of the four-membered rings and gave the nine-
membered carbocycle 174 in good yield over two steps.  
 
 
Scheme 26 | [2+2]-Photoaddition/cycloreversion strategy for the asymmetric total synthesis of 140. 
 
 
2.1.2.2 Phomoidrides A and B  
In the last decades, several groups have targeted phomoidrides A (150) and B (151) due to their strong 
biological activities and structural complexity.73 In 1999, Nicolaou published the first racemic total 
synthesis of phomoidrides A (150) and B (151) (Scheme 27).74 The formation of the 
bicyclo[4.3.1]decene core 176 was accomplished by a type II intramolecular Diels–Alder reaction of 
cyclization precursor 175. For the introduction of the maleic anhydride moiety, carboxylic ester 177 was 
converted into nitrile 178 followed by a one-pot tandem sequence including mesylation of the primary 
                                                     
72 a) J. D. White, M. P. Dillon, R. J. Butlin, J. Am. Chem. Soc. 1992, 114, 9673–9674; b) J. D. White, J. Kim, N. E. Drapela, J. 
Am. Chem. Soc. 2000, 122, 8665–8671. 
73 For a review see: D. A. Spiegel, J. T. Njardarson,I. M. McDonald, J. L. Wood Chem. Rev. 2003, 103, 2691–2727. 
74 a) K. C. Nicolaou, J. Jung,W. H. Yoon, K. C. Fong,H. S. Choi, Y. He, Y. L. Zhong, P. S. Baran, J. Am. Chem. Soc. 2002, 
124, 2183–2189. b) K. C. Nicolaou, P. S. Baran, Y. L. Zhong, K. C. Fong, H. S. Choi, J. Am. Chem. Soc. 2002, 124, 2190–
2201. c) K. C. Nicolaou, J. Jung, W. H. Yoon, K. C. Fong, H. S. Choi, Y. He, Y. L. Zhong, P. S. Baran, J. Am. Chem. Soc. 
2002, 124, 2183–2189. d) K. C. Nicolaou, P. S. Baran, Y. L. Zhong, K. C. Fong, Y. He, W. H. Yoon, H. S. Choi, Angew. Chem. 
Int. Ed. 1999, 38, 1676–1678. e) K. C. Nicolaou, P. S. Baran, Y. L. Zhong, H. S. Choi, W. Yoon, Y. He, K. C. Fong, Angew. 
Chem. Int. Ed. 1999, 38, 1669–1675. f) K. C. Nicolaou, Y. He, K. C. Fong, W. H. Yoon, H. S. Choi, Y. L. Zhong, P. S. Baran, 
Org. Lett. 1999, 1, 63–66. g) K. C. Nicolaou, P. S. Baran, Angew. Chem. Int. Ed. 2002, 41, 2678–2720. h) K. C. Nicolaou.M. 
W. Harter, L. Boulton, B. Jandeleit, Angew. Chem. Int. Ed. 1997, 36, 1194–1196. 
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alcohol, epoxide formation, β-elimination, cyclization, autoxidation and ammonia release. Maleic 
anhydride 179 was then converted into 150 in 20 steps. The last cyclization from phomoidrides A (150) 
to phomoidrides B (151) was accomplished by treatment of 150 with methanesulfonic acid in 
chloroform. Interconversion studies showed that by treatment of 151 with lithium hydroxide in a 
tetrahydrofuran, water mixture can be converted back into 150. Later, Nicolaou developed an 
enantioselective synthesis of phomoidrides A (150) and B (151).75  
 
 
Scheme 27 | First racemic total synthesis of phomoidrides A (150) and B (151) by Nicolaou. The type II IMDA 
reaction and formation of the anhydride are highlighted. 
 
To date, additional three total syntheses of phomoidrides A (150) and B (151) have been reported by 
Fukuyama,76 Shair77 and Danishefsky.78 
 
                                                     
75 a) K. C. Nicolaou, J. Jung, W. H. Yoon, Y. He, Y. L. Zhong, P. S. Baran, Angew. Chem. Int. Ed. 2000, 39, 1829–1832. b) 
K. C. Nicolaou, Y. L. Zhong, P. S. Baran, J. Jung, H. S. Choi, W. H. Yoon, J. Am. Chem. Soc. 2002, 124, 2202–2211. 
76 a) N. Waizumi, T. Itoh, T. Fukuyama, Tetrahedron Lett. 1998, 39, 6015–6018. b) N. Waizumi, T. Itoh, T. Fukuyama, J. Am. 
Chem. Soc. 2000, 122, 7825–7826. 
77 a) C. Chen, M. E. Layton, M. D. Shair, J. Am. Chem. Soc. 1998, 120, 10784–10785. b) C. Chen, M. E. Layton, S. M. Sheehan, 
M. D. Shair, J. Am. Chem. Soc. 2000, 122, 7424–7425. 
78 a) D. F. Meng, Q. Tan, S. J. Danishefsky, Angew. Chem. Int. Ed. 1999, 38, 3197–3201. b) O. Y. Kwon, D. S. Su, D. F. Meng, 
W. Deng, D. C. D’Amico, S. J. Danishefsky, Angew. Chem. Int. Ed. 1998, 37, 1877–1880. c) O. Y. Kwon, D. S. Su, D. F. 
Meng, W. Deng, D. C. D’Amico, S. J. Danishefsky, Angew. Chem. Int. Ed. 1998, 37, 1880–1882. d) D. F. Meng, S. J. 
Danishefsky. Angew. Chem. Int. Ed. 1999, 38, 1485–1488. e) Q. Tan, S. J. Danishefsky, Angew. Chem. Int. Ed. 2000, 39, 4509–
4511. 
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2.1.2.3 Cornexistin and hydroxycornexistin  
Cornexistin (148) and hydroxycornexistin (149) show both significant herbicidal activity against certain 
young annual and perennial monocotyledonous and dicotyledonous plants with weak phytotoxicity to 
corn. Due to their potent herbicidal bioactivity and the synthetically unexplored nonadrine skeleton, 148 
and 149 have been targeted in several synthetic studies. The first attempt to access the nine-membered 
ring of 148 and 149 by the Taylor group in 2007 features a ring expansion of 180 to 181 via an 
ozonolysis-olefination sequence. However, the Taylor group was never able to invert the 
stereochemistry of the C-2 hydroxyl group of 181 (Scheme 1).79 
 
 
Scheme 28 | Synthetic route to the nine-membered carbocycle of 148 and 149 by the Taylor group. 
 
The Clark group was confronted with a similar problem in their synthesis of the carbocyclic core 
structure of the cornexistins by ring-closing metathesis.  
 
 
Scheme 29 | Synthesis of (±)-5-epi-hydroxycornexistin (186). 
 
Treatment of a diastereomeric mixture of 183 with Grubbs’ second generation catalyst (20 mol%) gave 
the desired nine-membered ring as a mixture of diastereomers 184 and 185. The desired, minor isomer 
184 was further transformed into 5-epi-hydroxycornexistin (186) in eight steps. Despite numerous 
                                                     
79 J. C. Tung, W. Chen, B. C. Noll, S. C. Fields, W. H. Dent, F. R. Green, R. E. Taylor, Synthesis 2007, 15, 2388–2396. 
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effords to invert the stereochemistry of the hydroxy function at C-2 position, 149 could never be 
prepared.80 
 
 
2.1.3 Maleic Anhydride 
One of the key moieties that feature all members of the nonadride family is the maleic anhydride. Since 
an anhydride is a highly reactive species by default, it should be installed late stage in a synthetic route. 
Therefore, synthetically useful retrons for a maleic anhydride unit are needed. In the following selection 
the most common retrons and conversion thereof into maleic anhydrides are shown. 
 
 
Scheme 30 | Furan as a retron for maleic anhydride by either a) anodic oxidation or b) photooxidation. 
 
The furan, already containing the carbon/oxygen core, is one of the most common retrons for a maleic 
anhydride motive. In 1975, the group of Magnusson reported a stepwise procedure by initial anodic 
oxidation of furan 187 to 188. The electrolysis product 188 was then oxidized under Jones conditions to 
the desired anhydride 189 (Scheme 30a).81 Similar to the anodic oxidation procedure, exposure of 190 
to singlet oxygen generated a mixture of diastereo-and regioisomers of lactol 191. Further oxidation 
with pyridiniuim chlorochromate gave then the maleic anhydride 192. Especially the photochemical 
protocol has been applied in several total syntheses.82  
                                                     
80 a) F. Marlin, B. Nay, C. Wilson, J. S. Clark, Org. Lett. 2003, 5, 89–89. b) J. M. Northall, F. Marlin, B. Nay, C. Wilson, A. J. 
Blake, M. J. Waring, J. S. Clark, Org. Biomol. Chem. 2008, 6, 4012–4025. 
81 J. Froborg, G. Magnusson, S. Thóren, J. Org. Chem. 1975, 40, 122–123. 
82 For selected examples see: a) P.F. Vlad et al., Tetrahedron 2013, 69, 918–926. b) T. Nakano, J. Villamizar, M. A. Maillo, J. 
Chem. Res. 1998, 560–561. c) C. L. Hugelshofer, T. Magauer, J. Am. Chem. Soc. 2015, 137, 3807−3810. 
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In 2014, the group of Tsuji reported a nicker-catalyzed double carboxylation of internal alkynes with 
carbon dioxide (1 atm). The reaction proceeds under carbon dioxide atmosphere at ambient temperature 
in the presence of a nickel catalyst, zinc as a reducing agent and magnesium bromide. With this 
methodology, various internal alkynes such as 193 could be transformed into the corresponding maleic 
anhydride 194 (Scheme 31a).83 
 
 
Scheme 31 | Alkynes as a retron for maleic anhydrides. 
 
Similar to this methodology, the group of Ogoshi demonstrated that cyanoformates (195) add across 
alkynes (196) to give β-cyano acrylates (197). Those highly functionalized adducts could be hydrolyzed 
to give disubstituted maleic anhydride 198 (Scheme 31b).84  
The hexacarbonyldicobalt acetylene complex (199) was found to be a viable precursor for a maleic 
anhydride unit (200) first reported by P. Chen (Scheme 31c).85 This transformation was found by 
attempted oxidative decomplexation of 199 with ceric ammonium nitrate (CAN) forming the maleic 
anhydride 200 in excellent yield. Although the mechanism for this transformation is still under 
investigation, this methodology has been applied in numerous synthetic sequences.86 
                                                     
83 T. Fujihara, Y. Horimoto, T. Mizoe, F. B. Sayyed, Y Tani, J. Terao, S Sakaki, Y Tsuji, Org. Lett. 2014, 16, 4960−4963. 
84 Y. Hirata, A. Yada, E. Morita, Y. Nakao, T. Hiyama, M. Ohashi, S. Ogoshi, J. Am. Chem. Soc. 2010, 132, 10070–10077. 
85 M. J. Schottelius, P. Chen, Helv. Chim. Acta 1998, 81, 2341–2347. 
86 For selected examples see: K. Tanino, T. Shimizu, M. Miyama, I. Kuwajima, J. Am. Chem. Soc. 2000, 122, 6116–6117. b) 
K. Mitachi, T. Yamamoto, F Kondo, T. Shimizu, M. Miyashita, K. Tanino, Chem. Lett. 2010, 39, 630–632. c) M. Kinebuchia, 
R. Uematsua, K. Tanino, Tetrahedron Lett. 2017 58, 1382–1386. 
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Scheme 32 | Ozonolytic conversion of hydroquinone 201 into maleic anhydride 203. 
 
Inspired by Stork’s synthesis of byssochlamic acid (140), the group of U. Koert reported the first 
literature precedence of a selective ozonolytic conversion of hydroquinone 201 into maleic anhydride 
203. Although, ozonolysis of the corresponding benzoquinone of 201 also led to the formation of the 
dicarboxylic acid, a significant amount of side products was isolated. It is hypothesized that the phenolic 
hydroxyl groups led to a precoordination of ozone which then leads to the observed high selectivity of 
the oxidative cleavage (Scheme 32).  
 
 
Scheme 33 | Synthesis of a maleic anhydride fused to a nine-membered carbocycle. 
 
As demonstrated by K. I. Booker-Milburn, β-ketoesters such as 204 could be easily transformed into 
enol triflate 205. In a subsequent palladium-mediated carbonylation, the maleic anhydride 206 could be 
installed (Scheme 33).87 In 2018, this sequence was also applied for the installation of the maleic 
anhydride moiety in Wood’s total synthesis of phomoidride D.88 
 
  
                                                     
87 M. J. Ralph, D. C. Harrowven, S. Gaulier, S. Ng, K. I. Booker-Milburn, Angew. Chem. Int. Ed. 2015, 54, 1527–1531. 
88 J. C. Leung, A. A. Bedermann, J. T. Njardarson, D. A. Spiegel, G. K. Murphy, N. Hama, B. M. Twenter, P. Dong, T. 
Shirahata, I. M. McDonald, M. Inoue, N. Taniguchi, T. C. McMahon, C. M. Schneider, N. Tao, B. M. Stoltz, J. L. Wood, 
Angew. Chem. Int. Ed. 2018, 57, 1991–1994. 
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2.1.4 9-Membered Carbocycles: Strategies and Tactics for their 
Synthesis 
 
 
 
 
Reprinted with permission from: 
T. Huber†, R. E. Wildermuth†, T. Magauer, Chem. Eur. J. 2018, 24, 12107–12120. 
Copyright © 2018 John Wiley and Sons. 
 
 
† These authors contributed equally to this work. 
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2.2 Results and Discussion 
2.2.1 First Generation: Conia-ene cyclization 
For the synthesis of cornexistin (148) we envisioned to synthesize the carbon skeleton 208 via a Conia-
ene cyclization of β-keto ester 209. The hydroxyl moiety at C-2 should be introduced by alpha 
hydroxylation, the exocyclic Z-configured double bond by intramolecular ring-closing metathesis with 
an allyl silyl ether and the anhydride moiety by oxidation of the furan with singlet oxygen. The 
cyclization precursor 209 can be dissected into two readily building blocks, allyl bromide 210 and 3,4-
dibromofuran 211. 
 
 
Scheme 34 | Retrosynthetic analysis of 148. 
 
The synthesis of 3,4-dibromofuran (211) has been reported by several groups with yields in the range 
of 40–83%.89 However, we were never able to reproduce those results and 211 was only isolated in 
traces.  
 
 
Scheme 35 | Synthesis of 3,4-dibromofuran (211) 
                                                     
89 a) G. A. Kraus, X. Wang, Synth. Commun. 1998, 28, 1093–1096. b) S. P. H. Mee, V. Lee, J. E. Baldwin, A. Cowley, 
Tetrahedron 2004, 60, 3695–3712. c) D. Rennison, S. Bova, M. Cavalli, F. Ricchelli, A. Zulian, B. Hopkins, M. A. Brimble, 
Bioorg. Med. Chem. 2007, 15, 2963–2974. d) J. Min, P. Wang, S. Srinivasan, J. C. Nwachukwu, P. Guo, M. Huang, K. E. 
Carlson, J. A. Katzenellenbogen, K. W. Nettles, H. Zhou, J. Med. Chem. 2013, 56, 3346–3366. 
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Constant removal of the product from the reaction mixture by water steam distillation was the key to 
success to isolate five grams of 211 in a single batch with reproducible yield of around 30% (Scheme 
35).90 
With 211 in hand we now investigated the synthesis of allyl bromide 210. Starting from L-(–)-malic acid 
(213), one carboxylic acid group was selectively esterified by first formation of the mixed anhydride 
with trifluoroacetic anhydride followed by reaction with ethanol. Reduction of the free carboxylic acid 
functionality with borane dimethylsulfide complex afforded diol 215 in good overall yield. After silyl 
protection of the primary alcohol, the secondary alcohol 216 was protected with 
allyl(chloro)dimethylsilane The disilyl ether 217 turned out to be instable and thus the envisioned 
Kulinkovich reaction failed (Scheme 36).91 
 
 
Scheme 36 | Envisioned formation of 218 via Kulinkovich reaction. 
 
Then, we focused on the synthesis of another precursor for the Kulinkovich reaction without the labile 
silyl protection group. Starting from L-(–)-malic acid (213), 221 was synthesized accordingly to the 
foregoing protocol and was subjected to Kulinkovich conditions. Unfortunately, no conversion to 222 
was observed (Scheme 37).92 
 
 
Scheme 37 | Envisioned formation of 222 via Kulinkovich reaction. 
 
                                                     
90 See supporting information for reaction setup. 
91 For the synthesis of 216 see: A. T. Radosevich, C. Musich, F. D. Toste, J. Am. Chem. Soc. 2005, 127, 1090–1091. 
92 A. Mames, S. Stecko, P. Mikołajczyk, M. Soluch, B. Furman, M. Chmielewski, J. Org. Chem. 2010, 75, 7580–7587. 
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Giving the fact, that the Kulinkovich reaction is more favored if ring strain is released during the 
reaction, malic acid derivative 22393 was TBS protected and then successfully converted into 
cyclopropanol 225 under Kulikovich conditions. It was crucial for a successful reaction to add the ethyl 
Grignard over a period of four hours keeping the temperature at 10 °C, as well as the use of freshly 
distilled titanium iso-propoxide. The primary alcohol of 225 was then protected by silyl ether formation 
to give 226. The tertiary alcohol was mesylated, followed by magnesium bromide etherate promoted 
fragmentation to give allylbromide 210 (Scheme 36).  
 
 
Scheme 38 | Synthesis of allyl bromide 210. 
 
With allylbromide 210 in hands, we now investigated the coupling of 210 and 211. The monometalation 
of 211 was already investigated in earlier studies working in excellent yields.94 Dibromide 211 was first 
treated with n-butyl lithium followed by addition of magnesium bromide etherate to form the 
corresponding Grignard compound. Allyl bromide 210 was then coupled in presence of catalytic 
amounts of copper(I)-bromide to afford 227 in very good yield (Scheme 39).  
 
 
Scheme 39 | Fragment coupling yielding of 210 and 211. 
 
Formylation of 227, by bromine/lithium exchange followed by addition of N,N-dimethylformamide, 
gave aldehyde 228 that was treated with the Ohira–Bestmann reagent to give alkyne 229. Subsequent 
selective cleavage of the primary TBS-ether with pyridinium p-toluenesulfonate provided alcohol 230 
in good overall yields. After oxidation with Dess–Martin periodinane, 231 was transformed into 
cyclization precursor 232 by Buechner–Curtius–Schlotterbeck reaction (Scheme 40).  
 
                                                     
93 S. Yang, S. E. Denmark, J. Am. Chem. Soc. 2004, 126, 12432–12440. 
94 T. Huber (2017) Studies Toward the Total Syntheses of Waixenicin A and Jerantinine E. PhD Thesis. LMU Munich. 
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Scheme 40 | Synthesis of cyclization precursor 232. 
 
In 2007, the group of E. Nakamura published an indium catalyzed Conia-ene cyclization of ω-alkynyl-
β-ketoesters into six to fifteen-membered rings.95 For nine-membered rings, the cyclization proceeds 
smoothly if the cyclization precursor contains two or more sp2-centers due to reduced ring strain. Based 
on this methodology we started to investigate the cyclization of our substrate 232 (Scheme 41). 
 
 
 
Scheme 41 | Indium(III) promoted 9-exo-dig cyclization of 232. 
 
After treatment of 232 with indium(III) tris(trifluoromethanesulfonimide) in toluene at 100 °C, traces of 
an inseparable mixture, composed of two compounds was isolated. Based on 2D-NMR spectroscopic 
data, one showed a new exo-methylene group (234) the other a new methyl group (233). The reaction 
conditions were further optimized (In(NTf2)3 1 mol%, toluene, 120 °C) to give a mixture of 233 and 234 
(yield 35–45%). It was crucial for the reaction mixture to keep the catalyst loading below 3%, otherwise 
full decomposition was observed.  
 
                                                     
95 a) H.Tsuji, K. Yamagata, Y. Itoh, K. Endo, M. Nakamura, E. Nakamura, Angew. Chem. Int. Ed. 2007, 46, 8060–8062. b) Y. 
Itoh, H. Tsuji, K.Yamagata, K. Endo, I. Tanaka, M. Nakamura, E. Nakamura, J. Am. Chem. Soc. 2008, 130, 17161–17167. 
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Scheme 42 | Synthesis of nine-membered carbocycle 236. 
 
Decarboxylation of the isomeric mixture of β-keto esters 233 and 234 following the Krapcho protocol 
gave a mixture of 235 and 236 with the silyl ether partially cleaved. The crude mixture was directly 
treated with pyridinium hydrofluoride to yield the free alcohol 236 in 30% yield over three steps.  
At this point we were interested in the nine-membered ring’s conformation as well as in an unambiguous 
structural confirmation of 236. Unfortunately, owing to the oily texture of 236, crystals for X-Ray 
diffraction analysis could not be collected. Therefore, the secondary alcohol was transformed into the 
ferrocene carboxylic ester 237 and crystals suitable for single-crystal X-ray diffraction were obtained 
by recrystallization from ethyl acetate. The crystal structure reveals a boat-like conformation of the nine-
membered ring blocking the β-side of the enone and exposing its α-side (e.g. for Weitz–Scheffer 
epoxidation) (Scheme 43). 
 
Scheme 43 | Formation of the ferrocene carboxylic ester 237. 
 
Encouraged by this results we then investigated extension of the scope to non-terminal alkynes. 
Synthesis of the desired cyclization precursor commenced with alkyne 229 which was deprotonated 
with sodium bis(trimethylsilyl)amide and then alkylated with ethyl iodide to give 238. Selective 
deprotection of the primary silyl ether provided the free primary alcohol 239 that was subjected to the 
already established oxidation (DMP). The subsequent Roskamp reaction sequence yielding decent 
quantities of cyclization precursor 209 (Scheme 44). 
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Scheme 44 | Synthesis of the non-terminal alkyne 209. 
 
After extensive screening, no condition was found to selectively form the nine-membered ring (Table 
2). This result correlates with the reported cyclization strategies95 in which non-terminal alkynes were 
never used as cyclization precursors. For the proposed double activation of the 1,3-diketone and the 
alkyne, a non-terminal alkyne differs electronically as well as sterically from a terminal alkyne 
preventing the desired cyclization. Due to this drawback, we decided to abandon this route, and focus 
on an approach that was investigated in parallel and already gave some promising results. 

Table 2 | Selected screening conditions for the 9-exo-dig cyclization of the non-terminal alkyne 209. 
 
Entry Catalyst Solvent Temperature Time Result 
1 In(NTf2)3 Toluene 140 °C 8 h no reaction 
2 In(NTf2)3 Toluene 180 °C 24 h no reaction 
3 In(OTf)3, DBU Toluene 120 °C 12 h decomposition 
 
 
2.2.2 Second Generation: NHK reaction at the eastern half 
In parallel, the formation of the nine-membered ring via an intramolecular Nozaki–Hiyama–Kishi 
(NHK) reaction was investigated. We envision a modular synthetic route that introduces the C-2-
hydroxy group via enantioselective epoxidation of enone 242, followed by epoxide opening using a 
metalated propyl species. This would lead to 243 as cyclization precursor for an intramolecular Barbier-
type reaction. The Z-iodide moiety should be available by Stork–Wittig olefination of aldehyde 228, a 
substrate already used in the forgoing approach and available in large quantities (Scheme 45). 
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Scheme 45 | 2nd Generation retrosynthetic analysis of 148.  
 
Following a modified Stork–Wittig protocol, aldehyde 228 was transformed into vinyl iodide 244 in 
excellent yields and high Z-selectivity (Z/E 10/1).96 It is noteworthy, if potassium 
bis(trimethylsilyl)amide was used as base, a 1:1 mixture of (E)-244 and (Z)-244 was obtained. After 
selective cleavage of the primary silyl ether, 244 was oxidized with Dess–Martin periodinane to give 
the desired cyclization precursor 243 in very good yields (Scheme 46).  
 
 
Scheme 46 | Synthesis of the cyclization precursor 243.  
 
In literature, three examples for the formation of a nine-membered carbocycle via an intramolecular 
NHK reaction haven been reported.97 Inspired by these conditions, we began to investigate the formation 
of the nine-membered carbocycle 244. Following the NHK protocol (CrCl2, NiCl2, DMF), the nine-
membered carbocycle 244 was obtained as a single diastereomer. 
 
 
 
 
 
 
 
                                                     
96 J. J. Mousseau, J. A. Bull, C. L. Ladd, A. Fortier, D. S. Roman, A. B. Charette, J. Org. Chem. 2011, 76, 8243–8261. 
97 For a review see: T. Huber, R. Wildermuth, T. Magauer, Chem. Eur. J. 2018, 24, 12107–12120. 
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Table 3 | Screening of the nine-membered ring formation. 
 
Entry Catalyst Solvent Conc. Yield 
1 CrCl2 (7.5equiv), NiCl2 (0.07 equiv) DMSO/Me2S 0.005 M 244 (23%) 
2 CrCl2 (7.5equiv), NiCl2 (0.07 equiv) DMF 0.005 M 
244 (28%) 245 
(traces) 
3 CrCl2 (7.5equiv), Ni(acac)2 (0.07 equiv) DMF 0.005 M 
244 (26%) 245 
(traces) 
4 CrCl2 (7.5equiv), NiCl2 (0.07 equiv) DMF 0.05 M 244 (17%) 
5 CrCl2 (7.5equiv), NiCl2 (1 equiv) DMF 0.005 M 244 (23%) 245 (17%) 
6 CrCl2 (7.5equiv), NiCl2 (0.07 equiv) DMF 0.005 M 244 (17%)a  
7 t-BuLi (2.6 equiv) THF 0.005 M 244:246 (1:3)b  
8 t-BuLi (2.6 equiv) THF 0.005 M 244:246 (1:2)c  
9 In DMA 0.005 M n.r.d  
10 In, LiCl THF 0.01 M n.r.e 
11 In, LiCl THF, H2O 0.01 M n.r.e 
12 Mg THF 0.005 M n.r. 
13 Zn, TMSCl, (BrCH2)2 THF 0.005 M n.r. 
a 100 mg scale; b –78 °C; c –100 °C; d 23 °C to 100 °C; e 0 °C to 55 °C, n.r. no reaction. 
 
Encouraged by this initial result, different solvents, nickel(II) sources and concentrations were 
investigated (Table 3). DMSO, Me2S and DMF as solvent gave the desired product 244 in similar yields 
(Entry 1 and 2). Since DMF showed slightly better yields and significant shorter reaction times (DMF 
16 h, DMSO/Me2S 40 h), DMF was used as solvent of choice for further screening reactions. Applying 
Ni(acac)2 as the nickel(II) source gave 244 in 26% yield (Entry 3). It is noteworthy, that Ni(acac)2 
decreased the reaction time to 6 hours. Increasing the concentration by a factor of ten, led to a drastic 
decrease of the yield and and a significant number of byproducts was formed (Entry 4). If nickel(II) 
chloride was applied in stoichiometric amounts, significant amounts of side product 245 were formed 
(Entry 5). Although, all Nozaki–Hiyama–Kishi reaction conditions provided the nine-membered 
carbocycle 244, we were not able to improve the yield of this transformation. With tert-butyllithium, we 
were able to perform an iodine/lithium exchange followed by subsequent intramolecular Barbier 
reaction to yield an inseparable mixture of the desired product 244 and 246 (Entry 7). In order to suppress 
the 1,2-addition of tert-butyllithium, we decreased to temperature to –100 °C and to our delight, the 
amount of side product 246 decreased as well (Entry 8). Unfortunately, we were not able to tune this 
reaction to a viable transformation on preparative scale. Metalation with indium, zinc or magnesium 
were also not successful and starting material was recovered (Entry 9–13).  
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Scheme 47 | Oxidation of 244 to enone 242 and Scheffer–Weitz epoxidation to 247.  
 
With hands on small quantities of the cyclization product, 244 was oxidized to enone 242 with Dess–
Martin periodinane. Enone 242 was then subjected to the Scheffer–Weitz epoxidation protocol giving 
an inseparable mixture of two compounds. Based on 2D-NMR spectroscopic data, one was assigned to 
the desired epoxide 247 as a single diastereoisomer. This synthetic studies have shown that the NHK-
reaction possess a viable method for the formation of nine-membered carbocycle. Unfortunately, the 
product was only obtained in low yield which further decreased upon scale-up and also the following 
steps were low yielding with just traces of the desired products (<1 mg). Thus, a new route, employing 
a precursor that already contains the complete decoration of cornexistin (148) was devolved.  
 
 
2.2.3 Third Generation: NHK reaction at the western half 
In our new strategy, the nine-membered carbocycle should be formed via a late-stage NHK reaction. 
The anhydride moiety should be derived from an alkyne complexed by dicobalt octacarbonyl (cf. 
Chapter 2.1.3). Contrary to our initial approach, the challenging stereocenters on the eastern part of 
cornexistin (148) should already be set in the beginning of our route. The Z-configured exocyclic double 
bond should be introduced by alkylation of alkyne 252 with 251. The anti-geometry of the hydroxyl- 
and the n-propyl group in the eastern part of the molecule could be accessed by a syn-Evans-aldol 
reaction of aldehyde 253 and valeroyl derivative 25498. 
 
                                                     
98 F. Soucy, L. Grenier, M. L. Behnke, A. T. Destree, T. A. McCormack, J. Adams, L. Plamondon, J. Am. Chem. Soc. 1999, 
121, 9967–9976. 
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Scheme 48 | 3rd generation retrosynthetic analysis of cornexistin (148). 
 
After borane reduction of L-(–)-malic acid (213) to triol 255, benzylidene acetal 256 was formed in 
excellent yield. Swern oxidation of the primary alcohol provided the desired aldehyde 253, that proved 
to be prone to polymerization and was therefore directly used in the following step.99  
 
 
Scheme 49 | Synthesis of aldehyde 253. 
 
With aldehyde 253 and 254 in hand, we investigated the syn-Evans-aldol reaction. With dibutylboryl 
trifluoromethanesulfonate as Lewis acid, 257 was obtained as a single diastereoisomer. It is noteworthy, 
that the quality of the dibutylboryl trifluoromethanesulfonate (1 M in CH2Cl2) determines the success of 
the aldol reaction in terms of diastereoselectivity and yield. The stereochemistry was unambiguously 
assigned by X-ray single crystal diffraction. After silyl protection of the secondary alcohol, 258 was 
obtained in good yields and large quantities over two steps. Slow recrystallization from a mixture of 
hexanes and ethyl acetate yielded crystals suitable for X-ray single crystal diffraction (Scheme 50).  
 
                                                     
99 a) L. W. Erickson, E. L. Lucas, E. J. Tollefson, E. R. Jarvo, J. Am. Chem. Soc. 2016, 138, 14006–14011. b) W. R. Judd, S. 
Ban, J. Aubé, J. Am. Chem. Soc. 2006, 128, 13736–13741. c) R. W. Hoffmann, G. Mas, T. Brandl, Eur. J. Org. Chem. 2002, 
3455–3464. 
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Scheme 50 | Synthesis of alkyne 252 and X-ray structures of 257 and 258. 
 
Since the benzylidene acetal might be cleaved under reductive conditions, we decided to remove the 
Evans-auxiliary by first formation of the thioester 259 which can then be further reduced under mild 
conditions. The odorless alternative with dodecanethiol also provided the respective thioester but in 
lower yield (46%). Thioester 259 was then reduced to aldehyde 260 applying the Fukuyama protocol.100 
Due to the acidic nature of Pd/C,101 it was crucial to buffer the reaction mixture with sodium bicarbonate, 
otherwise cleavage of the benzylidene acetal was observed. Homologation with Ohira–Bestmann 
reagent led to the formation of a complex mixture and only traces of alkyne 252 were isolated. 
Fortunately, following the Corey–Fuchs homologation102 protocol provided 252 in good overall yield 
(Scheme 50).  
 
 
Scheme 51 | Synthesis of Z-iodide 265. 
 
                                                     
100 For a review see: T. Fukuyma, H. Tokuyama, Aldrichimica Acta 2004, 37, 87–96. 
101 For the preparation of Pd/C see: Org. Synth. 1946, 26, 77. 
102 E. J. Corey, P. L. Fuchs, Tetrahedron Lett. 1972, 13, 3769–3772. 
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The synthesis of the Z-iodide 265 commenced with a reported sequence for allylic alcohol by the Cook 
group, starting from crotonaldehyde (262).103 The allylic alcohol 264 was then converted into a good 
leaving. Although, nosylate 265 proved to be unstable on silica, sufficient quantities (500 mg) of 265 
were obtained as a solid that was substantially more stable than the respective allyl bromide 251 (Scheme 
51).  
 
 
Scheme 52 | Fragment coupling of 252 and 265 followed by reductive opening of the PMB-acetal. 
 
With both fragments 252 and 265 in hands, we turned our attention to the SN2 displacement with alkyne 
252.104 To our delight, the SN2 pathway was predominately operative and only traces of the SN2’ product 
were observed. The coupling product 266 was obtained as an inseparable mixture with unreacted alkyne 
252. After reductive opening of the benzylidene acetal of 266 and 252, we were able to separate the 
desired product 267 from 268 (Scheme 50). 
 
 
Scheme 53 | Synthesis of cyclization precursor 250 and attempted cyclization.  
 
After oxidation with Dess–Martin periodinane, the stage was set to investigate the cyclization of 250. 
Unfortunately, various conditions to form 270 (CrCl2, NiCl2, Ni(acac)2, t-BuLi) only resulted in the 
isolation of a dehalogenated species. This indicates, metalation at the vinylic position occurred but the 
cyclization is geometrically disfavored. Further investigating this hypothesis, the system was 
geometrically optimized by formally exchanging the sp hybridized carbons of the alkyne by sp2 
hybridized carbons (Figure 5).  
                                                     
103 W. Yin, M. S. Kabir, Z. Wang, S. K. Rallapalli, J. Ma, J. M. Cook, J. Org. Chem. 2010, 75, 3339–3349. 
104 a) D. F. Taber, P. Gu, R. Li, J. Org. Chem. 2009, 74, 5516–5522. b) Brandon R. Smith, J. T. Njardarson, Org. Lett., 2017, 
19, 5316–5319. 
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Figure 5 | Geometrical optimizations. 
 
Alkene 271 should serve as a proof of concept showing that a Z-configured double bond facilitates the 
cyclization. But selective reduction of 269 with diimide only resulted in a complex mixture.105 Alkynes 
can undergo a [3+2] cycloaddition with 4-phenyl-oxazole106 forming 3,4-substituted furans.107 However, 
this reaction requires relatively harsh conditions (200 °C, neat) and lead in our case just to 
decomposition of the starting material. We successfully synthesized cyclization precursor 273 by 
complexation of alkyne 269 with dicobalt octacarbonyl followed by oxidation of the alcohol. But this 
complex was highly instable and decomposed under NHK conditions. Also the oxidation of 273 directly 
to the anhydride resulted in a complex mixture.85,86 At this stage, we decided to abandon this route, due 
to more promising developments in our group. 
 
 
2.2.4  Fourth Generation: Intermolecular alkylation 
Based on this results, we developed a new route to cornexistin, still employing syn-Evans-aldol building 
block 258 from the previous route. The anhydride moiety should be formed by palladium catalyzed 
carbonylation of enol triflate 275. The key step, the formation of the nine-membered ring should be 
realized by an intramolecular allylation of β–keto ester 276. The cyclization precursor can be dissected 
into the building blocks 277 and 278 which is readily available from 258 (Scheme 54). 
 
                                                     
105 D. J. Pasto, R. T. Taylor, Org. React. 1991, 40, 91–155. 
106 For the synthesis of this reagent see: S. E. Whitney, M. Winters, B. Rickborn, J. Org. Chem. 1990, 55, 929–935. 
107 J. Boukouvalas, C. Thibault, R. P. Loach, Synlett 2014, 25, 2139–2142. 
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Scheme 54 | 4th Generation retrosynthetic analysis of cornexistin (148). 
 
Our synthesis commenced with aldol product 258 and reduction of the Evans-auxiliary to the primary 
alcohol 279. Although literature reports excellent yields (up to 96%) for this step,108 we were never able 
to obtain 279 in more than 64% yield. The primary alcohol was then silyl protected and after reductive 
opening of the benzylidene acetal and oxidation of the primary alcohol, we were able to obtain 1.3 g of 
aldehyde 278 (Scheme 55).  
 
 
Scheme 55 | Synthesis of aldehyde 278. 
 
Next, the addition of Z-viny-iodide 277 into aldehyde 278 via an intramolecular Nozaki–Hiyama–Kishi 
reaction was investigated (Table 4). Unfortunately, treatment of a mixture of iodide 277 and aldehyde 
278 in DMF with chromium(II) chloride and catalytic amount of nickel(II) chloride did not show any 
formation of the desired product (Entry 1).109 Also all halogen/metal exchange attempts of 285 just 
resulted in the isolation of the starting material (Entry 2–4).  
 
                                                     
108 E. M. Stang, M. C. White, Nat. Chem 2009, 1, 547–551. 
109 R. E. Taylor, J. P. Ciavarri, Org. Lett. 1999, 1, 467–470. 
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Table 4 | Conditions for the introduction of the Z-methyl building block. 
 
Entry R Conditions Solvent Yield 
1 OAc CrCl2, NiCl2 DMF n.r. 
2 OTBS Mg Et2O n.r. 
3 OTBS t-BuLi Et2O n.r. 
4 OTBS n-BuLi THF n.r. 
5 OTES CrCl2, NiCl2 DMF α/β-283 (64%) 
6 OTMS CrCl2, NiCl2 then HCl DMF α/β-284 (41%) 
 
To our surprise, TES-protected iodide 286 reacted under NHK conditions forming allylic alcohol as a 
mixture of α-283 and β-283 isomers (d.r. 2.1). Since the TES-ether had to be cleaved in the next step 
(60% HF•py in THF, 0 °C) and therefore increasing the overall step count of our route, TMS-protected 
iodide 287 was coupled with aldehyde 278. Upon acidic workup, the TMS-ether was cleaved giving an 
inseparable mixture of α-284 and β-284. 
 
 
Scheme 56 | Synthesis and separation of the diastereomers α-290 and β-290 by column chromatography. 
 
Diol 284 was acetylated at the primary alcohol followed by formation of the MOM-ether of the 
secondary alcohol giving an inseparable mixture of the α/β-289 isomers. The primary TBS-ether was 
then selectively cleaved by treatment with hydrogen fluoride in pyridine. At this step, we were able to 
separate α-290 from β-290 by flash column chromatography on silica gel. With the separated isomers 
in hand, we continued to investigate two different cyclization approaches. With the minor β-290 isomer, 
we proceeded to investigate a palladium-catalyzed cyclization.110 The synthesis of cyclization precursor 
β-293 for this strategy proceeded uneventfully in two steps (Scheme 57).  
 
                                                     
110 a) P. A. Clarke, R. J. G. Black, A. J. Blake, Tetrahedron Lett. 2006, 47 1453–1455. b) P. A. Clarke, R. J. G. Black, M. Iqbal, 
Synlett 2010, 543–546. 
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Scheme 57 | Synthesis of cyclization precursor β-293. 
 
Unfortunately, treatment of β-293 with the reported conditions only resulted in a complex mixture with 
no evidence of the desired product β-294 (Scheme 58). 
 
 
Scheme 58 | Attempted palladium catalyzed cyclization of 293. 
 
In parallel, major isomer α-290 was converted into cyclization precursor α-276 by oxidation of the 
primary alcohol with Dess–Martin periodinane, Roskamp reaction, saponification of the acetyl 
protecting group and Appel reaction. It is noteworthy, that cleavage of the acetyl protecting group in 
methanol with potassium carbonate lead to transesterification of the ethyl ester to the methyl ester. With 
allybromide α-276 in hand, the base promoted cyclization was investigated.  
 
 
Scheme 59 | Synthesis of the cyclization precursor α-276. 
 
The envisioned key-step, the formation of the nine-membered ring via intramolecular alkylation, was 
investigated by C. Steinborn.111 In this preliminary studies, we were able to shows that isomeric nine-
membered carbocycles 299 and 300 can be formed in excellent yield by treatment of 298 with potassium 
carbonate in acetonitrile (Scheme 60).  
                                                     
111 C. Steinborn (2018) Synthetic studies towards herbicidal natural products. Master Thesis. LMU Munich. 
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Scheme 60 | Formation of the nine-membered carbocycle of model substrate α-298. 
 
Based on this result, we adopted those conditions for the cyclization of α-276, giving a mixture of α-301 
(single isomer), enol α-302 and O-alkkylation product α-303 (Table 5, Entry 3). Encouraged by this 
result, various bases were tested of which lithium and sodium carbonate did not show any reaction (Entry 
1, 2). Cesium and silver carbonate showed increased formation of the undesired O-alkylation product α-
303 (Entry 4, 5) accompanied by a significant amount of side products. Changing the solvent from 
acetonitrile to DMF, did not improve the product distribution in favor of α-301 or α-302 (Entry 7, 8). 
The best result was obtained with DBU in acetonitrile giving a 2:1 mixture of the desired product and 
O-alkylation product α-303. On preparative scale, these conditions provided a mixture of α-301 or α-
302 in 56% yield.  
 
Table 5 | Screening of cyclization conditions. 
 
Entry Base Solvent Yield 301:302:303 
1a Li2CO3 MeCN n.r. 
2a Na2CO3 MeCN n.r. 
3a K2CO3 MeCN 1.7:0.1:1 
4a Cs2CO3 MeCN 1.5:0.2:1 
5a Ag2CO3 MeCN 1.3:0.0:1 
6a DBU MeCN 2.0:0.3:1 
7a NaH DMF 0.4:0.4:1 
8a Cs2CO3 DMF 1.0:0.7:1 
9b DBU MeCN 56% (mixture of 301 and 302) 
n.r. no reaction; a reactions were performed on 10 mg scale of 276 in 0.5 mL of solvent. b isolated yield; reaction was performed 
on 45 mg scale of α-276 in 3.5 mL of solvent. 
 
With cyclized products α-301 and α-302 in hand, we turned our attention to the formation of the 
enoltriflate. Treatment of a mixture of α-301 and α-302 with common triflation agents (Tf2O, Comins 
and McMurry reagent)112 did not show any formation of the desired product. In this context, we tried to 
form the enol-mesylate with methanesulfonyl chloride in the presence of base. To our surprise, when α-
301 and α-302 were reacted with triflic chloride in the presence of KHMDS, a new compound was 
                                                     
112 a) N. Su, J.A. Theorell, D. J. Wink, T. G. Driver, Angew. Chem. Int. Ed. 2015, 54, 12942–12946. b) V. Saini, M. O’Dair, 
M. S. Sigman, J. Am. Chem. Soc. 2015, 137, 608–611. 
RESULTS AND DISCUSSION 91 
 
 
formed within 10 minutes. After careful analysis of the obtained spectroscopic data (NMR, HRMS), the 
formed compound was assigned to chloride α-304.  
 
 
Scheme 61 | Formation of vinyl chloride α-304. 
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2.3 Conclusion and Outlook 
In summary, we have established a synthetic route towards cornexistin that addresses all the shortcoming 
of earlier synthesis. The challenging anti-relationship of the C-3 n-propyl side chain and the C-2 hydroxy 
group was set by an auxiliary controlled syn-Evans-aldol reaction. The Z-configured double bound was 
introduced via an intermolecular NHK reaction forming the third stereocenter as a diastereomeric 
mixture (d.r. 2:1). Nine-membered ring-formation was realized via an intramolecular alkylation of a β-
keto-ester and subsequent treatment of the cyclization product with triflic chloride provided chloride 
304. 
 
 
Scheme 62 | Remaining steps towards cornexistin (148) 
 
In the last steps, the anhydride moiety should be formed from 304 by palladium catalyzed carbonylation 
(cf. Chapter 2.1.3). After oxidative cleavage of the PMB-ether and subsequent oxidation of the 
secondary alcohol, global deprotection of the silyl ether and the MOM-ether would then provide 
cornexistin (148) (Scheme 62).  
 
 
Scheme 63 | a) Synthesis of the Z-iodide 308 and b) fragment coupling of 278 and 308 for the synthesis of 
hydroxycornexistin (149). 
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The structurally related natural product hydroxycornexistin (149) could then be synthesized accordingly. 
Intermolecular NHK reaction of iodide 311 (Scheme 63a) and aldehyde 278 would provide allylic 
alcohol 311 which could be transformed into hydroxycornexistin (149) according to the synthesis of 
cornexistin (148) (Scheme 63b).  
In future work, biological studies of cornexistin and hydroxycornexistin and derivatization thereof to 
further increase their herbicidal activity will be pursued in cooperation with Bayer Crop Science in 
Frankfurt, Germany.  
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3.1 Supporting Information for Chapter 1.2.1 
 
 
 
Gold(I)-Catalyzed Enyne Cyclizations: Studies Towards the Total 
Synthesis of (+)-Aureol 
 
 
 
R. Wildermuth, K. Speck, T. Magauer, Synthesis, 2016, 48, 1814–1824. 
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3.3 Supporting Information for Chapter 2.2 
3.3.1 General Experimental Details 
All reactions were carried out with magnetic stirring, and if moisture or air sensitive, under nitrogen or 
argon atmosphere using standard Schlenk techniques in oven-dried glassware (100 °C oven 
temperature). If required glassware was further dried under vacuum with a heat-gun at 650 °C. External 
bath thermometers were used to record all reaction temperatures. Low temperature reactions were 
carried out in a Dewar vessel filled with acetone/dry ice (T between –78 °C and 0 °C) or distilled 
water/ice (0 °C). High temperature reactions were conducted using a heated silicon oil bath or a metal 
block in reaction vessels equipped with a reflux condenser or in a pressure tube. Tetrahydrofuran (THF) 
was distilled over sodium/potassium alloy prior to use. All other solvents were purchased from Acros 
Organics as ‘extra dry’ reagents. All other reagents with a purity > 95% were obtained from commercial 
sources (Sigma Aldrich, Acros, Alfa Aesar and others) and used without further purification unless 
otherwise stated.  
Flash column chromatography (FCC) was carried out with Merck silica gel 60 (0.040–0.063 mm). 
Analytical thin layer chromatography (TLC) was carried out using Merck silica gel 60 F254 glass-
backed plates or aluminum foils and visualized under UV light at 254 nm. Staining was performed with 
ceric ammonium molybdate (CAM) or by staining with an aqueous anisaldehyde solution and 
subsequent heating.  
NMR spectra (1H NMR and 13C NMR) were recorded in deuterated chloroform (CDCl3) or methanol 
(MeOD-d4) on a Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbe™, a Bruker 
Avance Neo 400 MHz spectrometer, an Agilent 500 DD2 500 MHz spectrometer or a Bruker Avance II 
600 MHz spectrometer and are reported as follows: chemical shift δ in ppm (multiplicity, coupling 
constant J in Hz, number of protons) for 1H NMR spectra and chemical shift δ in ppm for 13C NMR 
spectra. Multiplicities are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = 
quintet, br = broad, m = multiplet, or combinations thereof. Residual solvent peaks of CDCl3 (δH = 
7.26 ppm, δC = 77.16 ppm) and MeOD-d4 (δH = 3.31 ppm, δC = 49.00 ppm) were used as internal 
reference. NMR spectra were assigned using information ascertained from COSY, HMBC, HSQC and 
NOESY experiments.  
High resolution mass spectra (HRMS) were recorded on a Varian MAT CH7A or a Varian MAT 711 
MS instrument by electron impact (EI) or electrospray ionization (ESI) techniques at the Department of 
Chemistry, Ludwig-Maximilians-University Munich or a Thermo Scientific™ LTQ Orbitrap XL™ 
Hybrid Ion Trap-Orbitrap Mass Spectrometer at the Institute of Organic Chemistry and Center for 
Molecular Biosciences, University of Innsbruck. 
Infrared spectra (IR) were recorded from 4000 cm−1 to 450 cm−1 on a Bruker™ ALPHA FT-IR 
Spectrometer from Bruker. Samples were prepared as a neat film or a film by evaporation of a solution 
 
 
in CDCl3. IR data in frequency of absorption (cm−1) is reported as follows: w = weak, m = medium, s = 
strong, br = broad or combinations thereof.  
Melting Points were measured with a SRS MPA120 EZ-Melt Melting Point Apparatus in open glass 
capillaries and are uncorrected. 
Optical rotation values were recorded on a Schmidt+Haensch UniPol L1000 Peltier polarimeter. The 
specific rotation is calculated as follows: [𝛼]𝜆
𝑇 = 
∝ × 100
𝑐 × 𝑑
. Thereby, the wavelength λ is reported in nm 
and the measuring temperature in °C. α represents the recorded optical rotation, c the concentration of 
the analyte in 10 mg/mL and d the length of the cuvette in dm. Thus, the specific rotation is given in 
10−1·deg·cm2 g−1. Use of the sodium D line (λ = 589 nm) is indicated by D instead of the wavelength in 
nm. The sample concentration as well as the solvent is reported in the relevant section of the 
experimental part. 
X-ray diffraction analysis was carried out by Prof. Dr. Klaus Wurst at the Institute of Organic 
Chemistry and Center for Molecular Biosciences, University of Innsbruck. The data collections were 
performed on a Bruker D8Quest using MoKα-radiation (λ = 0.71073 Å, Incoatec Microfocus). The 
Bruker Apex III software was applied for the integration, scaling and multi-scan absorption correction 
of the data. The structures were solved by direct methods with SHELXTL-XT-2014 and refined by least-
squares methods against F2 with SHELXL-2014/7. All non-hydrogen atoms were refined 
anisotropically. The hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further 
details are summarized in the tables at the different sections. Plotting of thermal ellipsoids in this 
document and in the main text was carried out using MERCURY for Windows. 
All yields are isolated, unless otherwise specified.  
 
 
3.3.2 First Generation: Conia-ene cyclization 
3,4-Dibromofuran (211) 
 
To a solution of trans-2,3-dibromo-2-butene-1,4-diol (212) (20.0 g, 81.3 mmol, 1 equiv) in aqueous 
sulfuric acid (7.5%, 50 mL), which was heated to 130 °C, was added dropwise a solution of potassium 
dichromate (24.7 g, 84.0 mmol, 1.05 equiv) in concentrated sulfuric acid (21 mL) and water (95 mL) 
over a period of 90 min. Bromide 211 was constantly distilled from the reaction mixture by water steam 
distillation (Figure 6). After 2 h, the distillate was extracted with n-pentane (3 × 250 mL) and the 
combined organic extracts were washed with aqueous saturated sodium bicarbonate (100 mL) and 
aqueous saturated sodium chloride solution (100 mL). The washed solution was dried over magnesium 
sulfate, the dried solution was filtered and the filtrate was concentrated (>200 mbar, 20 °C) to yield 211 
(98% in n-pentane, 5.77 g, 31%) as a yellow oil. The obtained analytical data for 211 were in full 
agreement with those reported in the literature.113 The crude product was used without further 
purification. 
 
Figure 6 | Experimental set-up for the synthesis of 3,4-dibromofuran (211): 1 distillate; 2 potassium dichromate 
in aqueous sulfuric acid; 3 reaction mixture (130 °C); 4 water steam generator (150 °C).  
                                                     
113 J. Min, P. Wang, S. Srinivasan, J. C. Nwachukwu, P. Guo, M. Huang, K. E. Carlson, J. A. Katzenellenbogen, K. W. Nettles, 
H. Zhou, J. Med. Chem. 2013, 56, 3346–3366. 
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Ketal S01 
 
Ketal S01 was prepared according to the procedure described by S. E. Denmark.114 
To a suspension of L-(–)-malic acid (213) (50.0 g, 373 mmol, 1 equiv) in 2,2-dimethoxypropane 
(185 mL, 1.49 mol, 4.00 equiv) was added p-toluenesulfonic acid monohydrate (709 mg, 3.73 mmol, 
0.0100 equiv) at 23 °C. After 3 h, a solution of sodium bicarbonate (313 mg, 3.73 mmol, 0.0100 equiv) 
in water (200 mL) and dichloromethane (150 mL) was added. The layers were separated and the aqueous 
layer was extracted with dichloromethane (3 × 150 mL). The combined organic extracts were dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated to give S01 (56.4 g, 
87%) as a colorless solid. The obtained characterization data were in full agreement with the values 
previously reported.  
 
(R)-3-hydroxydihydrofuran-2(3H)-one (223) 
 
(R)-3-hydroxydihydrofuran-2(3H)-one (223) was prepared according to the procedure described by S. 
E. Denmark.114 
A solution of borane tetrahydrofuran complex (1 M in tetrahydrofuran, 335 mL, 335 mmol, 1.10 equiv) 
was added to a solution of S01 (53.1 g, 305 mmol, 1 equiv) in tetrahydrofuran (300 mL) over a period 
of 1 h at 0 °C. After 1 h at 0 °C, the clear yellow reaction mixture was allowed to warm to 23 °C. After 
19 h, methanol (150 mL) was added over a period of 1 h. The reaction mixture was concentrated to give 
S02 as a colorless oil that was used without further purification.  
p-Toluenesulfonic acid monohydrate (612 mg, 3.22 mmol, 0.0100 equiv) was added to a solution of 
crude S02 in benzene (500 mL). After 24 h, the reaction mixture was concentrated and the residue was 
purified by flash column chromatography on silica gel (70% ethyl acetate in hexanes) to give 223 
(12.9 g, 39% over 2 steps) as a colorless oil. The obtained characterization data were in full agreement 
with the values previously reported.   
                                                     
114 S. Yang, S. E. Denmark, J. Am. Chem. Soc. 2004, 126, 12432–12440. 
 
 
Silyl ether 224 
 
tert-Butyldimethylchlorosilane (20.9 g, 139 mmol, 1.10 equiv) was added to a solution of 223 (12.9 g, 
126 mmol, 1 equiv) and imidazole (18.9 g, 278 mmol, 2.20 equiv) in N,N-dimethylformamide 
(500 mL). After 12 h, water (1 L) and diethyl ether (500 mL) were added. The layers were separated 
and the aqueous layer was extracted with diethyl ether (2 × 500 mL). The combined organic extracts 
were sequentially washed with aqueous lithium chloride solution (10wt%, 1 L) and saturated aqueous 
sodium chloride (1 L) solution. The washed solution was dried over magnesium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to give 224 (17.2 g, 63%) as a yellow oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.47 (KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 4.43–4.33 (m, 2H), 4.22–4.15 (m, 1H), 2.50–2.41 (m, 1H), 2.27–2.16 
(m, 1H), 0.91 (s, 9H), 0.16 (s, 3H), 0.14 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 176.1, 68.3, 64.9, 32.4, 25.8, 18.3, –4.6, –5.1. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2858, 1783, 1472, 1361, 1252, 1148, 1020, 836, 778. 
HRMS (EI) calc. for C9H17O3Si [M–CH3]+: 201.0941; found: 201.0935. 
[𝒂]𝑫
𝟐𝟎 = +33.4° (c = 13.1, CH2Cl2).  
 
 
Cyclopropanol 225 
 
A solution of ethylmagnesium bromide (3 M in diethyl ether, 39.4 mL, 118 mmol, 3.00 equiv) was 
added to a solution of 224 (8.53 g, 39.4 mmol, 1 equiv) and freshly distilled titanium(IV) iso-propoxide 
(13.0 mL, 43.4 mmol, 1.10 equiv) in tetrahydrofuran (150 mL) over a period of 4 h at 0 °C. After 
complete addition, saturated aqueous ammonium chloride solution (30 mL) was added to the black 
solution. The resulting grey suspension was filtered through a plug of Celite®. The filtrate was 
concentrated and the residue was purified by flash column chromatography on silica gel (40% ethyl 
acetate in hexanes) to give 225 (8.70 g, 90%) as a colorless oil. 
TLC (40% ethyl acetate in hexanes): Rf = 0.15 (KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 3.88–3.80 (m, 1H), 3.71–3.64 (m, 1H), 3.39 (t, J = 5.4 Hz, 1H), 3.08–
3.01 (m, 2H), 2.01–1.91 (m, 1H), 1.89–1.80 (m, 1H), 0.89 (s, 9H), 0.86–0.81 (m, 1H), 0.77–0.71 (m, 
1H), 0.56–0.48 (m, 2H), 0.07 (s, 3H), 0.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 74.6, 58.6, 58.3, 37.4, 26.0, 18.2, 14.1, 10.4, –4.1, –4.7. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3348, 2955, 2930, 2858, 1472, 1253, 1097, 1013, 836, 775. 
HRMS (ESI) calc. for C12H30O3NSi+ [M+NH4]+: 264.1989; found: 264.1990. 
[𝒂]𝑫
𝟐𝟎 = –4.96° (c = 1.61, CH2Cl2). 
 
  
 
 
Silyl ether 226 
 
tert-Butyldimethylchlorosilane (7.04 g, 46.7 mmol, 1.30 equiv) was added to a solution of 225 (8.86 g, 
36.0 mmol, 1 equiv) and imidazole (6.36 g, 93.5 mmol, 2.6 equiv) in dichloromethane (300 mL). After 
3 h, saturated aqueous sodium bicarbonate solution (300 mL) was added to the white suspension. The 
layers were separated and the aqueous layer was extracted with dichloromethane (2 × 150 mL). The 
combined organic extracts were dried over magnesium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel (5% 
ethyl acetate in hexanes) to give 226 (11.6 g, 89%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.55 (KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 3.84–3.77 (m, 1H), 3.72–3.64 (m, 1H), 3.44 (t, J = 6.0 Hz, 1H), 3.25 
(s, 1H), 1.95–1.80 (m, 2H), 0.89 (s, 9H), 0.88 (s, 9H), 0.81–0.76 (m, 1H), 0.73–0.67 (m, 1H), 0.56–0.47 
(m, 2H), 0.07 (s, 3H), 0.07–0.02 (m, 9H). 
13C NMR (101 MHz, CDCl3): δ = 74.0, 59.5, 58.3, 38.0, 26.0, 26.0, 18.3, 18.3, 13.4, 10.4, –4.1, –4.6, –
5.2, –5.2. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3424, 2955, 2930, 2858, 1472, 1464, 1255, 1095, 835, 775. 
HRMS (ESI) calc. for C18H41O3Si2+ [M+H]+: 361,2589; found: 361.2589. 
[𝒂]𝑫
𝟐𝟎 = +2.52° (c = 1.58, CH2Cl2).  
 
 
Allyl bromide 210 
 
Methanesulfonyl chloride (3.42 mL, 43.3 mmol, 2.00 equiv) was added to a solution of 226 (7.80 g, 
21.6 mmol, 1 equiv) and triethylamine (12.0 mL, 86.5 mmol, 4.00 equiv) in diethyl ether (120 mL) at 
0 °C. After 1 h, aqueous phosphate buffer solution (pH = 7) (120 mL) was added to the white 
suspension. The layers were separated and the aqueous layer was extracted with diethyl ether 
(2 × 100 mL). The combined organic extracts were dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated.  
The residue was dissolved in dichloromethane (130 mL). Magnesium bromide ethyl etherate (15.6 g, 
60.6 mmol, 2.80 equiv) was added and the suspension was heated to 40 °C. After 2 h, the reaction 
mixture was cooled to 23 °C, water (150 mL) was added, the layers were separated and the aqueous 
layer was extracted with dichloromethane (2 × 100 mL). The combined organic extracts were dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (1% ethyl acetate in hexanes) to give 210 (4.53 g, 
50% over 2 steps) as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.68 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 5.30–5.25 (m, 2H), 4.51 (dd, J = 7.3, 4.9 Hz, 1H), 4.05–3.96 (m, 2H), 
3.73–3.60 (m, 2H), 1.83–1.70 (m, 2H), 0.90 (s, 9H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05–0.03 (m, 6H), 0.02 
(s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 148.0, 116.0, 70.5, 59.4, 40.3, 32.2, 26.1, 26.0, 18.4, 18.3, –4.6, –5.0,      
–5.1, –5.2. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2955, 2930, 2886, 2858, 1472, 1255, 1098, 920, 835, 776. 
HRMS (EI) calc. for C18H3981BrO2Si2 [M]+: 424.1651; found: 424.1607. 
[𝒂]𝑫
𝟐𝟎 = +2.94° (c = 1.63, CH2Cl2).  
 
 
Bromofuran 227 
 
A solution of n-butyllithium (2.2 M in hexanes, 9.77 mL, 21.7 mmol, 3.90 equiv) was added to a solution 
of 211 (6.28 g, 25.0 mmol, 4.50 equiv) in tetrahydrofuran (63 mL) at –78 °C. After 30 min, the reaction 
mixture was allowed to warm to 0 °C and magnesium bromide ethyl etherate (6.03 g, 23.4 mmol, 
4.20 equiv) and copper(I) bromide dimethyl sulfide complex (229 mg, 1.11 mmol, 0.200 equiv) were 
added. After 30 min, a solution of 210 (2.36 g, 5.56 mmol, 1 equiv) in tetrahydrofuran (30 mL) was 
added at 0 °C. After complete addition, the red solution was allowed to warm to 23 °C. After 2 h, water 
(150 mL) and diethyl ether (100 mL) were added. The layers were separated and the aqueous layer was 
extracted with diethyl ether (2 × 100 mL). The combined organic extracts were washed with saturated 
aqueous sodium chloride solution. The washed solution was dried over magnesium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (1% diethyl ether in n-pentane) to give 227 (2.57 g, 94%) as a yellow oil. 
TLC (2% diethyl ether in n-pentane): Rf = 0.30 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 7.42 (s, 1H), 7.22 (s, 1H), 5.05 (s, 1H), 4.65 (s, 1H), 4.34 (t, J = 6.2 
Hz, 1H), 3.73–3.60 (m, 2H), 3.20 (d, J = 17.5 Hz, 1H), 3.06 (d, J = 7.5 Hz, 1H), 1.80–1.72 (m, 2H), 
0.90 (s, 9H), 0.90 (s, 9H), 0.05 (d, J = 1.8 Hz, 9H), 0.02 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 148.9, 141.0, 140.9, 122.8, 111.3, 103.3, 72.6, 59.6, 39.9, 25.9, 25.9, 
25.0, 18.3, 18.2, –4.7, –5.1, –5.3. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 =2955, 2929, 2857, 1472, 1361, 1256, 1088, 908, 835, 776. 
HRMS (EI) calc. for C22H40BrO3Si2 [M–H]–: 487.1694; found: 487.1683. 
[𝒂]𝑫
𝟐𝟎 = –1.8° (c = 0.46, CH2Cl2). 
 
  
 
 
Aldehyde 228 
 
A solution of n-butyllithium (2.4 M in hexanes, 1.57 mL, 3.82 mmol, 2.00 equiv) was added to a solution 
of 227 (936 mg, 1.91 mmol, 1 equiv) in tetrahydrofuran (12 mL) at –78 °C. After 2 h, N,N-
dimethylformamide (1.48 mL, 19.1 mmol, 10.0 equiv) was added to the orange solution at –78 °C and 
the reaction mixture was allowed to warm to 23 °C. After 1 h, saturated aqueous ammonium chloride 
solution (100 mL) and diethyl ether (70 mL) was added. The layers were separated and the aqueous 
layer was extracted with diethyl ether (2 × 70 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (200 mL). The washed solution was dried over magnesium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash column chromatography on silica gel (5% ethyl acetate in hexanes) to give 228 (770 mg, 92%) as 
a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.37 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.92 (d, J = 0.7 Hz, 1H), 8.00 (d, J = 1.6 Hz, 1H), 7.27 (s, 1H), 5.03 
(s, 1H), 4.62 (s, 1H), 4.35 (dd, J = 7.3, 5.1 Hz, 1H), 3.73–3.59 (m, 2H), 3.46–3.33 (m, 2H), 1.83–1.69 
(m, 2H), 0.89 (s, 9H), 0.89 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H), 0.03 (s, 3H), 0.00 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 185.1, 152.5, 150.0, 143.1, 127.5, 121.7, 111.0, 72.8, 59.7, 40.0, 26.1, 
26.0, 25.0, 18.4, 18.3, –4.6, –5.0, –5.2. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2929, 2885, 2857, 1694, 1255, 1089, 1048, 835, 775. 
HRMS (ESI) calc. for C23H42NaO4Si2+ [M+Na]+: 461.2514; found: 461.2489. 
[𝒂]𝑫
𝟐𝟎 = –23.7° (c = 0.21, CH2Cl2). 
 
  
 
 
Alkyne 229 
 
Potassium carbonate (2.43 g, 17.5 mmol, 10.0 equiv) was added to a solution of 228 (770 mg, 
1.75 mmol, 1 equiv) and S04 (674 mg, 3.51 mmol, 2.00 equiv) in methanol (12 mL). After 6 h, water 
(60 mL) and diethyl ether (60 mL) were added to the bright yellow suspension. The layers were 
separated and the aqueous layer was extracted with diethyl ether (2 × 50 mL). The combined organic 
extracts were washed with saturated aqueous sodium chloride solution (150 mL). The washed solution 
was dried over magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) to give 
229 (586 mg, 77%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.64 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.61 (d, J = 1.6 Hz, 1H), 7.18 (dq, J = 2.5, 1.6 Hz, 1H), 5.05 (s, 1H), 
4.70 (s, 1H), 4.33 (t, J = 6.2 Hz, 1H), 3.70–3.62 (m, 2H), 3.25 (d, J = 16.6 Hz, 1H), 3.13 (d, J = 16.6 
Hz, 1H), 3.06 (s, 1H), 1.75 (q, J = 6.4 Hz, 2H), 0.90 (s, 9H), 0.90 (s, 9H), 0.05–0.03 (m, 9H), 0.01 (s, 
3H). 
13C NMR (101 MHz, CDCl3): δ = 149.5, 146.8, 140.6, 124.3, 111.3, 108.7, 81.3, 74.4, 72.8, 59.8, 40.1, 
26.1, 26.0, 25.1, 18.4, 18.4, –4.5, –5.0, –5.1, –5.1. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3315, 2955, 2929, 2857, 1472, 1256, 1256, 1089, 1051, 835, 776. 
HRMS (ESI) calc. for C24H42NaO3Si2+ [M+Na]+: 457.2565; found: 457.2541.  
[𝒂]𝑫
𝟐𝟎 = –42.6° (c = 0.25, CH2Cl2). 
 
  
 
 
Alcohol 230 
 
Pyridine p-toluenesulfonate (353 mg, 1.41 mmol, 1 equiv) was added to a solution of 229 (611 mg, 
1.41 mmol, 1 equiv) in methanol (16 mL). After 3.5 h, saturated aqueous sodium bicarbonate solution 
(50 mL) and ethyl acetate (50 mL) were added. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (2 × 50 mL). The combined organic extracts were washed with saturated 
aqueous sodium chloride solution (150 mL). The washed solution was dried over magnesium sulfate. 
The dried solution was filtered and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (10% ethyl acetate in hexanes initially, grading to 20% ethyl 
acetate in hexanes) to give 230 (363 mg, 81%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.32 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 1H), 7.20 (s, 1H), 5.17 (s, 1H), 4.83 (s, 1H), 4.40 (t, J = 5.5 
Hz, 1H), 3.84–3.75 (m, 1H), 3.74–3.66 (m, 1H), 3.22 (d, J = 16.8 Hz, 1H), 3.11 (d, J = 16.8 Hz, 1H), 
3.08 (s, 1H), 2.32 (s, 1H), 1.93–1.78 (m, 2H), 0.90 (s, 9H), 0.06 (s, 3H), 0.02 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 148.6, 146.9, 140.6, 124.0, 111.9, 108.6, 81.4, 74.6, 74.3, 60.2, 37.9, 
26.0, 26.0, 18.3, –4.6, –5.2. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3400, 3305, 2954, 2929, 2887, 2857, 1256, 1083, 1051, 837. 
HRMS (ESI) calc. for C18H28NaO3Si+ [M+Na]+: 343.1700; found: 343.1682.  
[𝒂]𝑫
𝟐𝟎 = –13.9° (c = 0.14, CH2Cl2). 
 
  
 
 
Aldehyde 231 
 
Dess–Martin periodinane (624 mg, 1.47 mmol, 1.30 equiv) was added to a solution of 230 (363 mg, 
1.13 mmol, 1 equiv) and pyridine (357 µL, 4.42 mmol, 3.90 equiv) in dichloromethane (10 mL) at 0 °C. 
After 15 min, the white suspension was allowed to warm to 23°C. After 9 h, the reaction mixture was 
directly purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to give 
231 (337 mg, 93%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.76 (dd, J = 2.9, 2.1 Hz, 1H), 7.62 (d, J = 1.6 Hz, 1H), 7.21 (dt, J = 
1.6, 0.9 Hz, 1H), 5.19 (s, 1H), 4.84 (s, 1H), 4.67 (dd, J = 7.4, 4.4 Hz, 1H), 3.24 (d, J = 16.7 Hz, 1H), 
3.15 (d, J = 16.7 Hz, 1H), 3.08 (s, 1H), 2.67 (ddd, J = 15.7, 7.4, 2.9 Hz, 1H), 2.55 (ddd, J = 15.7, 4.4, 
2.1 Hz, 1H), 0.88 (s, 9H), 0.05 (s, 3H), 0.02 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 201.9, 148.1, 147.0, 140.7, 123.8, 112.6, 108.5, 81.6, 74.3, 71.2, 50.2, 
25.9, 25.8, 18.2, –4.5, –5.1. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3311, 2954, 2927, 2856, 1726, 1257, 1098,1050, 837, 778. 
HRMS (ESI) calc. for C18H26NaO3Si+ [M+Na]+: 341.1543; found: 341.1541. 
[𝒂]𝑫
𝟐𝟎 = –177.8° (c = 0.03, CH2Cl2). 
 
  
 
 
β-Ketoester 232 
 
Tin(II) chloride (100 mg, 529 µmol, 0.500 equiv) was added to a solution of 231 (337 mg, 1.06 mmol, 
1 equiv) and S06 (223 µL, 2.12 mmol, 2.00 equiv) in dichloromethane (8 mL). After 24 h, saturated 
aqueous ammonium chloride solution (50 mL) and dichloromethane (50 mL) were added. The layers 
were separated and the aqueous layer was extracted with dichloromethane (2 × 50 mL). The combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (5% ethyl acetate 
in hexanes) to give 232 (387 mg, 90%) as a colorless oil. 
Note: 232 was isolated as a mixture of keto-enol tautomers. Only the signals for the keto-tautomer are 
reported (assigned by 2D NMR analysis). 
TLC (30% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
1H NMR (400 MHz, CDCl3): 7.61 (s, 1H), 7.20 (s, 1H), 5.15 (s, 1H), 4.78 (s, 1H), 4.66 (dd, J = 8.4, 3.7 
Hz, 1H), 4.21–4.15 (m, 2H), 3.47 (s, 2H), 3.24–3.11 (m, 2H), 3.09 (s, 1H), 2.85 (dd, J = 15.1, 8.3 Hz, 
1H), 2.64 (dd, J = 15.2, 3.7 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 0.87 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 201.4, 167.2, 148.3, 146.9, 140.7, 123.8, 112.5, 108.5, 81.6, 74.3, 
72.3, 61.4, 51.1, 50.2, 25.9, 25.5, 18.2, 14.2, –4.6, –5.2. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3293, 2929, 2857, 1745, 1718, 1251, 1078, 1049, 835, 778. 
HRMS (ESI) calc. for C22H32NaO5Si+ [M+Na]+: 427.1911; found: 427.1896.  
  
 
 
Nine-membered carbocycle 233 and 234 
 
A Schlenk flask was charged with a solution of indium(III) tris(trifluoromethanesulfonimide) (0.0140 M 
in acetonitrile, 97.1 µL, 1.36 µmol, 0.0100 equiv). The solvent was removed under vacuum (0.1 mbar) 
at 60 °C. After 1 h, a solution of 232 (55.0 mg, 136 µmol, 1 equiv) in toluene (5 mL) was added at 23 °C 
and the reaction mixture was heated to 130 °C. After 3 h, the reaction mixture was allowed to cool to 
23 °C, diethyl ether (20 mL) was added and the yellow solution was filtered through a plug of silica. 
The filtrate was concentrated to yield a mixture of 233 and 234 that was directly used in the following 
step without further purification. 
 
 
Lithium chloride (28.8 mg, 680 µmol, 5.00 equiv) was added to a solution of the crude mixture of 233 
and 234 in dimethyl sulfoxide (1 mL) and the suspension was heated to 145 °C. After 2.5 h, the reaction 
mixture was allowed to cool to 23 °C, aqueous lithium chloride (10wt%, 50 mL) and diethyl ether 
(50 mL) were added. The layers were separated and the aqueous layer was extracted with diethyl ether 
(2 × 50 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution. The washed solution was dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was dissolved in tetrahydrofuran (0.8 mL) and pyridine 
hydrofluoride (pyridine ~30%, hydrogen fluoride ~70%; 0.2 mL) was added at 0 °C. After 1 h the 
reaction mixture was allowed to warm to 23 °C. After 2 h, saturated aqueous sodium bicarbonate 
solution (20 mL) was added followed by the addition of solid sodium bicarbonate until the gas evolution 
deceased. The biphasic mixture was extracted with ethyl acetate (3 × 20 mL). The combined organic 
extracts were washed with saturated sodium chloride solution. The washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) to give 236 (9 mg, 
30% over 3 steps) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.09 (UV, KMnO4). 
 
 
1H NMR (600 MHz, CDCl3): δ = 7.45 (s, 1H), 7.34 (s, 1H), 6.04 (d, J = 1.4 Hz, 1H), 5.09–5.05 (m, 
1H), 5.05–5.02 (m, 1H), 4.52–4.46 (m, 1H), 3.44 (d, J = 16.0 Hz, 1H), 3.29 (d, J = 16.0 Hz, 1H), 2.92–
2.88 (m, 1H), 2.71 (dd, J = 12.6, 7.1 Hz, 1H), 2.57 (d, J = 7.1 Hz, 1H), 2.20 (d, J = 1.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3): δ = 200.8, 147.1, 144.7, 141.7, 141.4, 131.2, 125.9, 122.4, 114.1, 72.5, 
45.6, 29.3, 28.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3406, 2927, 1635, 1527, 1438, 1377, 1143, 1056, 1021, 876. 
HRMS (ESI) calc. for C13H14NaO3+ [M+Na]+: 241.0835; found: 241.0828. 
[𝒂]𝑫
𝟐𝟎 = –40.4° (c = 0.17, CH2Cl2). 
  
 
 
Ferrocene carboxylic ester 237 
 
To a suspension of ferrocene carboxylic acid (15.6 mg, 67.8 µmol, 2.00 equiv) in dichloromethane 
(1.0 mL) was added oxalyl chloride solution (2 M in dichloromethane, 37.3 µL, 74.6 µmol, 2.20 equiv), 
followed by 1 drop of N,N-dimethylformamide at 23 °C. After 45 min, toluene (1 mL) was added and 
the mixture was concentrated. To a solution of 236 (7.40 mg, 33.9 µmol, 1 equiv) and 4-
dimethylaminopyridine (41.4 mg, 339 µmol, 10.0 equiv) in dichloromethane (0.5 mL) was added a 
solution of the freshly prepared ferrocenecarboxylic acid chloride in dichloromethane (0.5 mL) at 23 
°C. After 2 h, the reaction mixture was directly purified by flash-column chromatography on silica gel 
(dichloromethane) to yield 237 (9.70 mg, 67%) as an orange foam. Crystallization from ethyl acetate 
gave crystals suitable for X-ray diffraction. 
  
 
 
3.3.3 Second Generation: NHK reaction at the eastern half 
Vinyl iodide 244 
 
A solution of sodium hexamethyldisilazide (1 M in tetrahydrofuran, 1.51 mL, 1.51 mmol, 1.30 equiv) 
was added to a suspension of S07 (810 mg, 1.51 mmol, 1.30 equiv) in tetrahydrofuran (4 mL) at 0 °C. 
After 30 min, the yellow suspension was cooled to –78 °C and hexamethylphosphoric triamide (310 µL, 
1.75 mmol, 1.50 equiv) was added. After 5 min, a solution of 228 (516 mg, 1.16 mmol, 1 equiv) in 
tetrahydrofuran (1 mL) was added. After 10 min, the reaction mixture was allowed to warm to 23 °C. 
After 1.5 h, water (20 mL) and diethyl ether (20 mL) were added. The layers were separated and the 
aqueous layer was extracted with diethyl ether (2 × 20 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (60 mL). The washed solution was dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (1% ethyl acetate in cyclohexane) to give 244 
(625 mg, 95%, Z/E 10/1) as a colorless oil. 
TLC (10% ethyl acetate in cyclohexane): Rf = 0.64 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 8.41 (s, 1H), 7.24 (s, 1H), 7.05 (d, J = 8.4 Hz, 1H), 6.46 (d, J = 8.4 
Hz, 1H), 5.03 (s, 1H), 4.62 (s, 1H), 4.35–4.30 (m, 1H), 3.71–3.58 (m, 2H), 3.24 (d, J = 17.1 Hz, 1H), 
3.07 (d, J = 17.1 Hz, 1H), 1.78–1.70 (m, 2H), 0.91 (s, 9H), 0.90 (s, 9H), 0.06–0.05 (m, 6H), 0.05 (s, 
3H), 0.01 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 149.6, 141.1, 140.6, 129.7, 122.5, 121.8, 111.7, 79.4, 72.8, 59.7, 40.0, 
26.1, 26.0, 24.7, 18.4, 18.3, –4.5, –4.9, –5.1. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2953, 2928, 2886, 2856, 1471, 1314, 1143, 1090, 835, 775. 
HRMS (ESI) mass not found  
 
 
Alcohol S08 
 
Pyridine p-toluenesulfonate (28.2 mg, 111 µmol, 0.100 equiv) was added to a solution of 244 (625 mg, 
1.11 mmol, 1 equiv) in methanol (12 mL). After 24 h, pyridine p-toluenesulfonate (28.2 mg, 111 µmol, 
0.100 equiv) was added. After 3 h, saturated aqueous sodium bicarbonate solution (50 mL) and ethyl 
acetate (50 mL) were added. The layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 50 mL). The combined organic extracts were washed with saturated aqueous sodium 
chloride solution (150 mL). The washed solution was dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (10% ethyl acetate in cyclohexane) to give S08 (373 mg, 75%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf = 0.23 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 8.38 (s, 1H), 7.24 (s, 1H), 7.03 (dd, J = 8.6, 0.8 Hz, 1H), 6.48 (d, J = 
8.6 Hz, 1H), 5.14 (s, 1H), 4.73 (s, 1H), 4.39–4.33 (m, 1H), 3.78–3.68 (m, 2H), 3.19 (d, J = 17.1 Hz, 1H), 
3.06 (d, J = 17.1 Hz, 1H), 2.22 (s, 1H), 1.85–1.79 (m, 2H), 0.90 (s, 9H), 0.06 (s, 3H), 0.01 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 148.9, 141.2, 140.5, 129.5, 122.4, 121.4, 112.3, 79.8, 74.4, 60.1, 38.1, 
25.9, 25.7, 18.2, –4.6, –5.1. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3371, 2953, 2928, 2856, 1432, 1252, 1055, 836, 796, 776. 
HRMS (ESI) calc. for C18H29NaO3Si+ [M+Na]+: 471.0823; found: 471.0800. 
  
 
 
Aldehyde 243 
 
Dess–Martin periodinane (388 mg, 915 µmol, 1.10 equiv) was added to a solution of S08 (373 mg, 
832 µmol, 1 equiv) in dichloromethane (12 mL). After 1 h, cyclohexane (5 mL) was added and the 
mixture was directly purified by flash column chromatography on silica gel (5% ethyl acetate in 
cyclohexane) to give 243 (326 mg, 88%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf = 0.49 (UV, CAM). 
1H NMR (600 MHz, CDCl3): δ = 9.76–9.73 (m, 1H), 8.40 (s, 1H), 7.25 (s, 1H), 7.01 (d, J = 8.6 Hz, 
1H), 6.49 (d, J = 8.6 Hz, 1H), 5.17 (s, 1H), 4.75 (s, 1H), 4.66–4.63 (m, 1H), 3.21 (d, J = 17.3 Hz, 1H), 
3.08 (d, J = 17.3 Hz, 1H), 2.69–2.64 (m, 1H), 2.55–2.51 (m, 1H), 0.88 (s, 9H), 0.05 (s, 3H), 0.02 (s, 
3H). 
13C NMR (151 MHz, CDCl3): δ = 201.6, 148.1, 141.3, 140.6, 129.3, 122.3, 121.1, 113.0, 80.1, 71.2, 
50.2, 25.8, 25.4, 18.2, –4.5, –5.0. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2929, 2887, 2857, 1726, 1255, 1096, 1056, 837, 777. 
HRMS (ESI) calc. for C18H27INaO3Si+ [M+Na]+: 469.0666; found: 469.0643. 
  
 
 
Nine-membered carbocycle 244 
 
Note: N,N-Dimethylformamide was degassed via freeze-pump-thaw (three cycles) prior to use. 
Chromium(II) chloride (51.6 mg, 420 µmol, 7.50 equiv) and nickel(II) chloride (444 µg, 3.36 µmol, 
0.0600 equiv) were placed in a flamedried 50 mL Schlenk flask. The flask was evacuated and backfilled 
with nitrogen three times. The solids were suspended in N,N-dimethylformamide (11 mL) followed by 
the addition of a solution of 243 (25.0 mg, 56.0 µmol, 1 equiv) in N,N-dimethylformamide (0.5 mL). 
After 24 h, water (100 mL) and diethyl ether (100 mL) were added. The layers were separated and the 
aqueous layer was extracted with diethyl ether (3 × 80 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (150 mL). The washed solution was dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane) to give 244 
(5.10 mg, 28%) as a yellow oil. 
TLC (30% ethyl acetate in cyclohexane): Rf = 0.41 (UV, KMnO4). 
1H NMR (600 MHz, CDCl3): 7.29 (s, 1H), 7.17 (s, 1H), 6.16 (d, J = 11.0 Hz, 1H), 5.75 (dd, J = 11.0, 
8.5 Hz, 1H), 5.09 (s, 1H), 5.04 (s, 1H), 4.46 (t, J = 5.6 Hz, 1H), 4.33–4.27 (m, 1H), 3.33 (d, J = 14.9 Hz, 
1H), 3.06 (d, J = 14.9 Hz, 1H), 2.11 (ddd, J = 13.6, 5.6, 3.7 Hz, 1H), 2.01 (ddd, J = 13.6, 9.5, 5.6 Hz, 
1H), 0.90 (s, 9H), 0.07 (s, 3H), 0.02 (s, 3H). 
13C NMR (151MHz, CDCl3): 150.0, 140.1, 140.0, 139.6, 124.6, 121.9, 118.2, 114.2, 72.9, 67.3, 46.1, 
25.9, 25.8, 18.3, –4.8, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 33763, 2943, 2921, 2874, 1403, 1289, 1100, 821, 799, 741. 
HRMS (EI) calc. for C18H28NaO3Si [M+Na]+: 343.1700; found: 343.1717.  
 
 
3.3.4 Third Generation: NHK reaction at the western half 
Triol 255 
 
Triol 255 was prepared according to the procedure described by E. R. Jarvo.115 
L-(–)-malic acid (213) (4.32 g, 31.3 mmol, 1 equiv) was added to a solution of borane dimethyl sulfide 
(8.89 mL, 100 mmol, 3.20 equiv) and boric acid trimethyl ester (10.8 mL, 93.8 mmol, 3.00 equiv) in 
tetrahydrofuran (100 mL) at 0 °C. After complete addition, the reaction mixture was allowed to warm 
to 23°C. After 24 h, methanol (30 mL) was added dropwise over a period of 1 h. The reaction mixture 
was concentrated to provide 255 (3.32 g, 99%) as a colorless oil. The obtained analytical data for 255 
were in full agreement with those values previously reported. 
 
Acetal 256 
 
Camphor sulfonic acid (377 mg, 1.59 mmol, 0.0500 equiv) and p-anisaldehyde dimethyl acetal (S09) 
(7.21 mL, 41.4 mmol, 1.30 equiv) were added to a solution of 255 (3.38 g, 31.9 mmol) in 
dichloromethane (160 mL). After 12 h, imidazole (219 mg, 3.19 mmol, 0.100 equiv) was added and the 
reaction mixture was concentrated. The residue was purified by flash column chromatography on silica 
gel (35% ethyl acetate in cyclohexane) to give 256 (5.15 g, 83%) as a colorless oil. The obtained 
analytical data for 256 were in full agreement with those values previously reported.116 
  
                                                     
115 L. W. Erickson, E. L. Lucas, E. J. Tollefson, E. R. Jarvo, J. Am. Chem. Soc. 2016, 138, 14006–14011. 
116 W. R. Judd, S. Ban, J. Aubé, J. Am. Chem. Soc. 2006, 128, 13736–13741. 
 
 
Aldehyde 253 
 
Dimethyl sulfoxide (7.28 mL, 103 mmol, 2.30 equiv) was added to a solution of oxalyl chloride 
(4.76 mL, 49.1 mmol, 1.10 equiv) in dichloromethane (160 mL) at –78 °C over a period of 5 min. After 
15 min, a solution of 256 (10.0 g, 44.6 mmol, 1 equiv) in dichloromethane (60 mL) was added over a 
period of 10 min. After 1 h, trimethylamine (24.8 mL, 178 mmol, 4.00 equiv) was added to the turbid 
solution and the mixture was allowed to warm to 23 °C. After 30 min, water (200 mL) was added, the 
layers were separated and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The 
combined organic extracts were dried over magnesium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel (20% 
ethyl acetate in cyclohexane initially, grading to 50% ethyl acetate in cyclohexane) to give 253 (5.00 g, 
51%) as a colorless oil. The obtained analytical data for 253 were in full agreement with those values 
previously reported.117 
Note: 253 was used immediately in the following reaction, due to its tendency to polymerize. 
 
Oxazolidinone 254 
 
A solution of n-butyllithium (2.4 M in hexanes, 16.6 mL, 39.9 mmol, 1.10 equiv) was added to a solution 
of S11 (6.42 g, 36.2 mmol, 1 equiv) in tetrahydrofuran (100 mL) at –78 °C. After 1 h, valeryl chloride 
(S10) (4.95 mL, 39.9 mmol, 1.10 equiv) was added to the orange reaction mixture. After 30 min, the 
reaction mixture was allowed to warm to warm to 23 °C. After 2 h, water (300 mL) and ethyl acetate 
(100 mL) were added. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(2 × 150 mL). The combined organic extracts were dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (20% ethyl acetate in cyclohexane initially, grading to 50% ethyl acetate in cyclohexane) 
                                                     
117 R. W. Hoffmann, G. Mas, T. Brandl, Eur. J. Org. Chem. 2002, 3455–3464. 
 
 
to give 254 (7.84 g, 83%) as a colorless solid. The obtained analytical data for 254 were in full agreement 
with those values previously reported.118  
                                                     
118 G. B Gennäs, V. Talman, O. Aitio, E. Ekokoski, M. Finel, R. K. Tuominen, J. Yli-Kauhaluoma, J. Med. Chem. 2009, 52, 
3969–3981. 
 
 
Alcohol 257 
 
A solution of bibutylboron triflate (1 M in dichloromethane, 19.2 mL, 19.2 mmol, 1.10 equiv) was added 
via syringe pump over a period of 10 min to a solution of 254 (4.56 g, 17.5 mmol, 1 equiv) in 
dichloromethane (60 mL) at –78 °C. After 10 min, triethylamine (3.27 mL, 23.6 mmol, 1.35 equiv) was 
added via syringe pump over a period of 10 min. After 15 min, the yellow solution was allowed to warm 
to 0 °C. After 1 h, the reaction mixture was cooled to –78 °C and a solution of 253 (5.04 g, 22.7 mmol, 
1.30 equiv) in dichloromethane (15 mL) was added via syringe pump over a period of 10 min. After 
addition, the reaction mixture was allowed to gradually warm to 23 °C. After 12 h, the reaction mixture 
was cooled to 0 °C and a mixture of methanol (10 mL) and aqueous phosphate buffer solution (pH = 7) 
(20 mL) followed by a mixture of methanol (10 mL) and hydrogen peroxide solution (30wt% in water) 
were added sequentially. After 1 h, water (200 mL) was added, the layers were separated and the 
aqueous layer was extracted with dichloromethane (2 × 200 mL). The combined organic extracts were 
dried over magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
residue was filtered through a plug of silica and the obtained residue was used without further 
purification. An analytically pure sample of 257 was obtained by normal-phase semi-preparative HPLC 
purification using 10% iso-propanol in n-heptane initially, grading to 20% iso-propanol over in n-
heptane over 30 min as eluent (flow rate: 15 mL/min; column: Microsorb 60-8 Si Dynamax 250 × 
21.4mm (R00083121C); detection: 254 nm; retention time: 10.7 min). Recrystallization from ethyl 
acetate gave crystals suitable for single-crystal X-ray diffraction. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.14 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.40–7.36 (m, 2H), 7.33–7.25 (m, 3H), 7.15–7.11 (m, 2H), 6.86–6.81 
(m, 2H), 5.38 (s, 1H), 4.29–4.22 (m, 2H), 4.22–4.16 (m, 1H), 3.96–3.89 (m, 2H), 3.86–3.80 (m, 1H), 
3.76 (dd, J = 8.9, 3.8 Hz, 1H), 3.70 (s, 3H), 3.34 (dd, J = 13.3, 3.5 Hz, 1H), 3.17 (t, J = 8.6 Hz, 1H), 
2.48 (dd, J = 13.3, 10.4 Hz, 1H), 2.24 (d, J = 5.1 Hz, 1H), 1.93–1.82 (m, 3H), 1.82–1.71 (m, 1H), 1.41–
1.33 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ = 175.8, 160.3, 153.7, 135.7, 131.2, 129.3, 129.0, 127.9, 127.3, 113.7, 
101.5, 79.4, 75.2, 67.1, 65.7, 55.4, 55.3, 45.3, 38.4, 31.8, 28.8, 20.1, 14.5. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3469, 2960, 2929, 2870, 1775, 1696, 1385, 1250, 1211, 1101. 
HRMS (ESI) calc. for C27H33NNaO7+ [M+Na]+: 506.2149; found: 506.2108. 
[𝒂]𝑫
𝟐𝟎 = –15.3° (c = 0.67, CH2Cl2). 
 
 
Melting point: 123 °C. 
  
 
 
Silyl ether 258   
 
Tert-butyldimethylsilyl trifluoromethanesulfonate (5.33 mL, 22.8 mmol, 1.30 equiv) was added to a 
solution of 257 (8.46 g, 17.5 mmol, 1 equiv) and 2,6-lutidine (10.4 mL, 87.5 mmol, 5.00 equiv) in 
dichloromethane (250 mL) at –78 °C. After 30 min, the reaction mixture was allowed to warm to 23 °C. 
After 2.5 h, water (250 mL) was added, the layers were separated and the aqueous layer was extracted 
with dichloromethane (2 × 200 mL). The combined organic extracts were dried over magnesium sulfate. 
The dried solution was filtered and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (10% ethyl acetate in cyclohexane) to give 258 (7.40 g, 71% over 
two steps) as a colorless solid. Recrystallization from ethyl acetate gave crystals suitable for single-
crystal X-ray diffraction. 
TLC (10% ethyl acetate in cyclohexane): Rf  = 0.31 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.23–7.18 (m, 2H), 7.16–7.10 (m, 2H), 7.10–7.04 (m, 1H), 6.97–6.92 
(m, 2H), 6.67–6.62 (m, 2H), 5.16 (s, 1H), 4.09–4.01 (m, 2H), 3.95–3.87 (m, 1H), 3.83 (dd, J = 8.9, 7.4 
Hz, 1H), 3.75–3.61 (m, 2H), 3.50 (s, 3H), 3.48 (dd, J = 8.9, 4.0 Hz, 1H), 3.19 (dd, J = 13.2, 3.4 Hz, 1H), 
2.71 (t, J = 8.5 Hz, 1H), 2.22 (dd, J = 13.2, 10.7 Hz, 1H), 1.73–1.58 (m, 2H), 1.57–1.51 (m, 1H), 1.51–
1.41 (m, 1H), 1.20–1.08 (m, 2H), 0.79–0.72 (m, 12H), 0.00 (s, 3H), -0.03 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 175.8, 160.3, 153.6, 135.8, 131.3, 129.2, 128.9, 128.1, 127.2, 113.5, 
101.8, 81.5, 76.1, 67.2, 65.4, 55.3, 55.3, 47.2, 38.4, 33.7, 29.0, 26.2, 20.1, 18.4, 14.4, –3.2, –3.4. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2957, 2928, 2853, 1777, 1695, 1431, 1384, 1250, 1104, 861. 
HRMS (ESI) calc. for C33H47NNaO7Si+ [M+Na]+: 620.3014; found: 620.2965. 
[𝒂]𝑫
𝟐𝟎 = –34.4° (c = 0.16, CH2Cl2). 
Melting point: 141 °C. 
  
 
 
Thioester 259 
 
A solution of n-butyllithium (2.4 M, in hexanes, 2.20 mL, 5.29 mmol, 2.00 equiv) was added to a 
solution of ethanethiol (593 µL, 7.93 mmol, 3.00 equiv) in tetrahydrofuran (15 mL) at 0 °C. After 
30 min, the white suspension was cooled to –78 °C and a solution of 258 (1.58 g, 2.64 mmol, 1 equiv) 
in tetrahydrofuran (15 mL) was added. After addition, the reaction mixture was allowed to gradually 
warm to 23 °C. After 1 h, saturated aqueous ammonium chloride solution (100 mL) and diethyl ether 
(80 mL) were added. The layers were separated and the aqueous layer was extracted with diethyl ether 
(2 × 80 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution (200 mL). The washed solution was dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (5% ethyl acetate in cyclohexane) to give 259 (1.23 g, 96%) as a colorless oil. 
TLC (10% ethyl acetate in cyclohexane): Rf  = 0.37 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.42–7.37 (m, 2H), 6.89–6.84 (m, 2H), 5.42 (s, 1H), 4.29 (ddd, J = 
11.4, 5.1, 1.4 Hz, 1H), 4.01 (dd, J = 7.0, 3.8 Hz, 1H), 3.95–3.87 (m, 1H), 3.85–3.80 (m, 1H), 3.79 (s, 
3H), 2.94–2.83 (m, 2H), 2.82–2.74 (m, 1H), 2.08–1.96 (m, 1H), 1.76–1.68 (m, 2H), 1.59–1.53 (m, 1H), 
1.45–1.35 (m, 1H), 1.26 (t, J = 7.4 Hz, 4H), 0.94–0.88 (m, 12H), 0.08 (s, 3H), 0.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 201.6, 159.8, 131.2, 127.5, 113.4, 101.4, 78.7, 75.8, 67.0, 57.5, 55.3, 
31.4, 26.2, 25.6, 23.4, 20.7, 18.5, 14.8, 14.2, –3.6, –4.5. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2953, 2930, 2858, 1775, 1600, 1510, 1253, 1160, 1053, 836. 
HRMS (ESI) mass not found.  
[𝒂]𝑫
𝟐𝟎 = +16.7° (c = 1.03, CH2Cl2).  
 
 
Alkyne 252 
 
Sodium hydrogen carbonate (2.14 g, 25.5 mmol, 10.0 equiv) was added to a suspension of palladium on 
carbon (10 wt.%, 271 mg, 255 µmol, 0.100 equiv). After 1 h, a solution of 259 (1.23 g, 2.55 mmol, 
1 equiv) was added followed by the addition of triethylsilane (831 µL, 5.10 mmol, 2.00 equiv). After 
2 h, the reaction mixture was filtered through a plug of silica and the obtained residue was used without 
further purification. 
 
Triphenylphosphine (2.03 g, 7.65 mmol, 3.00 equiv) was added to a solution of carbon tetrabromide 
(1.28 g, 3.82 mmol, 1.50 equiv) in dichloromethane (20 mL) at 0°C. After 30 min the dark orange 
solution was cooled to –78 °C and a solution of crude 260 (1.08 g, 2.55 mmol, 1 equiv) in 
dichloromethane (20 mL) was added. After 15 min, the reaction mixture was allowed to warm to 0 °C. 
After 3 h, saturated, aqueous sodium chloride solution (100 mL) and diethyl ether (100 mL) were added. 
The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 90 mL). The 
combined organic extracts were washed with saturated aqueous sodium chloride solution (200 mL). The 
washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was filtered through a plug of silica and the obtained residue was used without 
further purification. 
A solution of n-butyllithium (2.4 M, in hexanes, 2.13 mL, 5.10 mmol, 2.00 equiv) was added to a 
solution of crude 261 (1.47 g, 2.55 mmol, 1 equiv) in tetrahydrofuran (14 mL) at –78 °C. After 3 h, the 
yellow solution was allowed to warm to 0 °C. After 1 h, water (90 mL) diethyl ether (100 mL) were 
added. The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 100 mL). 
The combined organic extracts were washed with saturated aqueous sodium chloride solution (200 mL). 
The washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (5% ethyl 
acetate in cyclohexane) to give 252 (497 mg, 47% over 3 steps) as a colorless oil.  
 
 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.50 (CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.45–7.39 (m, 2H), 6.91–6.84 (m, 2H), 5.49 (s, 1H), 4.35–4.27 (m, 
1H), 4.23–4.16 (m, 1H), 4.02–3.94 (m, 1H), 3.82–3.79 (m, 4H), 2.58–2.51 (m, 1H), 2.12 (d, J = 2.5 Hz, 
1H), 2.08–1.97 (m, 1H), 1.71–1.36 (m, 5H), 0.96–0.90 (m, 12H), 0.11 (s, 3H), 0.09 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 159.9, 131.4, 127.5, 113.5, 101.4, 85.5, 78.7, 76.4, 71.4, 67.1, 55.4, 
35.4, 32.8, 26.2, 25.6, 20.4, 18.5, 14.0, –3.5, –4.4. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3308, 2957, 2929, 2856, 1518, 1248, 1129, 1107, 831, 779. 
HRMS (ESI) calc. for C24H38NaO4Si+ [M+Na]+: 441.2432; found: 441.2417. 
[𝒂]𝑫
𝟐𝟎 = +13.6° (c = 1.11, CH2Cl2).  
 
 
Allylic alcohol 264 
 
264 was prepared according to a procedure described by J. M. Cook119: 
Potassium carbonate (11.8 g, 85.6 mmol, 1.20 equiv), iodine (36.6 g, 143 mmol, 2.00 equiv) and N,N-
dimethylpyridin-4-amine (1.76 g, 14.3 mmol, 0.200 equiv) were added to a solution of crotonaldehyde 
(262) (5.91 mL, 71.3 mmol, 1 equiv) in a mixture of tetrahydrofuran (175 mL) and water (175 mL). 
After 5 h, ethyl acetate (200 mL) and saturated aqueous sodium thiosulfate solution were added. The 
layers were separated and the organic phase was washed with saturated aqueous sodium thiosulfate 
solution (2 × 100 mL). The washed solution was concentrated, the residue was dissolved in a mixture 
of tetrahydrofuran (150 mL) and water (15 mL) followed by the slow addition of sodium borohydride 
(1.38 g, 35.7 mmol, 0.500 equiv). After 1 h, water (200 mL) and ethyl acetate (100 mL) were added. 
The layers were separated and the aqueous layer was extracted with ethyl acetate (2 × 100 mL). The 
combined organic extracts were washed with saturated aqueous sodium chloride solution (300 mL). The 
washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (10% ethyl acetate 
in cyclohexane) to give 264 (6.07 mg, 43% over 2 steps) as a colorless oil. The obtained analytical data 
for 264 was in full agreement with those values previously reported. 
  
                                                     
119 W. Yin, M. S. Kabir, Z. Wang, S. K. Rallapalli, J. Ma, J. M. Cook, J. Org. Chem. 2010, 75, 3339–3349. 
 
 
Nosylate 265 
 
Sodium hydride (60% mineral oil dispersion, 302 mg, 7.55 mmol, 2.50 equiv) was added to a solution 
of 264 in tetrahydrofuran (24 mL) at –78 °C. After 1 h, 4-nitrobenzenesulfonyl chloride (837 mg, 
3.78 mmol, 1.25 equiv) was added. After 1 h, water (100 mL) and diethyl ether (80 mL) were added. 
The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 70 mL). The 
combined organic extracts were washed with saturated aqueous sodium chloride solution (100 mL). The 
washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (20% ethyl acetate 
in cyclohexane) to give 265 (500 mg, 43%) as an off-white solid.  
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.46 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3): δ = 8.44–8.36 (m, 2H), 8.15–8.08 (m, 2H), 6.12 (qt, J = 6.4, 1.0 Hz, 1H), 
4.87 (p, J = 1.0 Hz, 2H), 1.74 (dt, J = 6.5, 1.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ = 150.8, 142.3, 139.2, 129.5, 124.4, 97.2, 78.8, 21.7. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3106, 2956, 1531, 1404, 1371, 1350, 1185, 1094, 924, 836. 
HRMS (ESI) mass not found. 
Melting point: 75 °C decomposition.  
 
 
Alcohol 267 
 
Copper(I) iodide (150 mg, 786 µmol, 1 equiv), potassium carbonate (304 mg, 2.20 mmol, 2.80 equiv) 
and sodium iodide (131 mg, 865 µmol, 1.10 equiv) were added to a solution of 252 (395 mg, 944 µmol, 
1.20 equiv) in N,N-dimethylformamide (5 mL). After 20 min, 265 (301 mg, 786 µmol, 1 equiv) was 
added. After 12 h, saturated ammonium chloride solution (50 mL) and diethyl ether (50 mL) were 
added. The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 50 mL). 
The combined organic extracts were washed with saturated aqueous sodium chloride solution (100 mL). 
The washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (10% ethyl 
acetate in cyclohexane) to give an inseparable mixture of 266 and unreacted 252. The mixture was used 
in the following reaction without further purification.  
 
A solution of diisobutylaluminum hydride (1 M in toluene, 5.90 mL, 5.90 mmol, 7.50 equiv) was added 
to the foregoing mixture of 266 and 252 in dichloromethane (8 mL) at –78 °C. The reaction mixture was 
allowed to warm to –10 °C over a period of 5 h. The reaction mixture was diluted with diethyl ether 
(100 mL) and water (240 µL), aqueous sodium hydroxide solution (15 wt.%, 240 µL) and water 
(590 µL) were added sequentially at 0 °C. After 15 min, magnesium sulfate was added. After 15 min, 
the suspension was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (10% ethyl acetate in cyclohexane) to give 267 (347 mg, 74% over 2 steps) 
and 268 (82.0 mg, 25% over 2 steps) as colorless oils. 
For 267:  
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.33 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.27–7.23 (m, 2H), 6.87–6.84 (m, 2H), 5.85 (qt, J = 6.4, 1.6 Hz, 1H), 
4.58 (d, J = 11.3 Hz, 1H), 4.39 (d, J = 11.3 Hz, 1H), 4.05 (ddt, J = 9.1, 3.9, 2.0 Hz, 1H), 3.83 (dt, J = 
9.1, 2.5 Hz, 1H), 3.79 (s, 3H), 3.70–3.64 (m, 2H), 3.43–3.39 (m, 2H), 2.52 (s, 1H), 2.38–2.31 (m, 1H), 
 
 
1.95–1.85 (m, 1H), 1.76–1.64 (m, 5H), 1.63–1.52 (m, 1H), 1.41–1.29 (m, 2H), 1.27 (dd, J = 6.4, 5.5 Hz, 
1H), 0.94–0.88 (m, 12H), 0.09 (s, 3H), 0.07 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 159.4, 131.1, 130.2, 129.9, 113.9, 102.6, 84.3, 80.6, 80.1, 74.8, 71.0, 
60.8, 55.3, 36.2, 36.1, 33.9, 30.7, 26.2, 22.0, 20.4, 18.6, 14.0, –3.5, –4.8. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3436, 2956, 2929, 2857, 1612, 1513, 1248, 1062, 1038, 834. 
HRMS (ESI) calc. for C28H46IO4Si+ [M+H]+: 601.2205; found: 601.2186. 
[𝒂]𝑫
𝟐𝟎 = –9.0° (c = 0.27, CH2Cl2). 
 
For 268: 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.25 (UV, CAM). 
1H NMR (600 MHz, CDCl3): δ = 7.27–7.24 (m, 2H), 6.87–6.84 (m, 2H), 4.57 (d, J = 11.3 Hz, 1H), 4.37 
(d, J = 11.2 Hz, 1H), 4.01–3.97 (m, 1H), 3.84 (dt, J = 9.0, 1.7 Hz, 1H), 3.78 (s, 3H), 3.71–3.61 (m, 2H), 
2.37–2.31 (m, 1H), 2.10 (dd, J = 2.5, 1.3 Hz, 1H), 1.94–1.86 (m, 1H), 1.71–1.66 (m, 2H), 1.61–1.54 (m, 
1H), 1.39–1.30 (m, 2H), 0.90 (t, J = 7.2, 1.3 Hz, 3H), 0.87 (s, 9H), 0.07 (d, J = 1.3 Hz, 3H), 0.06 (d, J = 
1.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3): δ = 159.4, 130.2, 130.0, 114.0, 85.1, 80.1, 74.7, 72.0, 71.1, 60.8, 55.4, 
35.8, 33.6, 30.8, 26.2, 20.3, 18.6, 14.0, –3.5, –4.7. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3439, 3308, 2956, 2929, 2857, 1613, 1587, 1247, 1036, 833. 
HRMS (ESI) calc. for C24H40NaO4Si+ [M+Na]+: 443,2588; found: 443.2574. 
  
 
 
Aldehyde 250 
 
Dess–Martin periodinane (49.6 mg, 117 µmol, 1.30 equiv) was added to a solution of 267 (54.0 mg, 
242 µmol, 1 equiv) dichloromethane (2 mL) at 0 °C. After 15 min, the white suspension was allowed to 
warm to 23°C. After 2 h, the reaction mixture was directly purified by flash column chromatography on 
silica gel (5% ethyl acetate in cyclohexane) to give 250 (46 mg, 86%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.33 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.73 (dd, J = 3.0, 1.7 Hz, 1H), 7.25–7.22 (m, 2H), 6.87–6.84 (m, 2H), 
5.90–5.83 (m, 1H), 4.57 (d, J = 11.3 Hz, 1H), 4.48–4.43 (m, 1H), 4.40–4.37 (m, 1H), 3.85 (dd, J = 8.5, 
1.9 Hz, 1H), 3.80 (s, 3H), 3.44–3.40 (m, 2H), 2.73–2.65 (m, 1H), 2.58–2.53 (m, 1H), 2.33–2.26 (m, 1H), 
1.76 (dt, J = 6.4, 1.5 Hz, 3H), 1.67–1.57 (m, 1H), 1.40–1.33 (m, 1H), 1.31–1.26 (m, 1H), 0.94–0.90 (m, 
3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
13C NMR (assigned by HSQC correlations): δ = 202.5, 131.2, 129.6, 112.9, 76.4, 75.0, 71.0, 55.0, 43.8, 
43.7, 36.7, 36.0, 33.6, 26.1, 21.9, 13.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2956, 2928, 2856, 1727, 1613, 1514, 1249, 1135, 1037, 835. 
HRMS (ESI) calc. for C28H43O4ISi+ [M+Na]+: 621.1868; found: 621.1849. 
[𝒂]𝑫
𝟐𝟎 = +7.4° (c = 0.32, CH2Cl2). 
  
 
 
3.3.5 Fourth Generation: Intermolecular alkylation 
Alcohol 279 
 
A solution of lithium borohydride (2 M in tetrahydrofuran, 7.80 mL, 15.6 mmol, 2.00 equiv) was added 
to a solution of 258 (4.66 g, 7.79 mmol, 1 equiv) and methanol (632 µL, 15.6 mmol, 2.00 equiv) in a 
mixture of diethyl ether (100 mL) and tetrahydrofuran (5 mL) at 0 °C. After 3 h, water (150 mL) and 
ethyl acetate (50 mL) were added. The layers were separated and the aqueous layer was extracted with 
ethyl acetate (2 × 100 mL). The combined organic extracts were washed with saturated aqueous sodium 
chloride solution (300 mL). The washed solution was dried over magnesium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column chromatography 
on silica gel (10% ethyl acetate in cyclohexane initially, grading to 20% ethyl acetate in cyclohexane) 
to give 279 (2.12 g, 64%) as a colorless oil. 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.28 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.39–7.36 (m, 2H), 6.89–6.86 (m, 2H), 5.46 (s, 1H), 4.29 (ddd, J = 
11.4, 5.0, 1.5 Hz, 1H), 4.01–3.94 (m, 2H), 3.91 (dd, J = 6.1, 3.0 Hz, 1H), 3.80 (s, 3H), 3.70 (d, J = 8.4 
Hz, 2H), 2.52 (s, 1H), 1.97–1.90 (m, 2H), 1.69–1.65 (m, 1H), 1.47–1.40 (m, 1H), 1.40–1.33 (m, 2H), 
1.23–1.16 (m, 1H), 0.92–0.88 (m, 12H), 0.13 (s, 3H), 0.12 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 160.0, 131.3, 127.4, 113.7, 101.3, 78.2, 76.7, 67.2, 64.2, 55.4, 44.9, 
30.3, 28.7, 26.1, 21.5, 18.3, 14.5, –4.0, –4.3. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3457, 2956, 2928, 2856, 1518, 1248, 1103, 1035, 830, 777. 
HRMS (ESI) calc. for C23H41O5Si+ [M+H]+: 425.2718; found: 425.2708. 
[𝒂]𝑫
𝟐𝟎 = +1.2° (c = 0.65, CH2Cl2). 
  
 
 
Silyl ether 280 
 
Tert-butyldimethylsilyl chloride (841 mg, 5.47 mmol, 1.10 equiv) was added to a solution of 279 
(2.11 g, 4.97 mmol, 1 equiv) and imidazole (983 mg, 9.94 mmol, 2.00 equiv) in dichloromethane 
(50 mL). After 3 h, water (100 mL) and dichloromethane (50 mL) were added. The layers were 
separated and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined 
organic extracts were dried over magnesium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (20% ethyl acetate 
in cyclohexane) to give 280 (2.42 g, 90%) as a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.64 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.42 (dd, J = 8.3, 1.6 Hz, 2H), 6.88 (dd, J = 8.3, 1.6 Hz, 2H), 5.45 (s, 
1H), 4.33–4.26 (m, 1H), 3.99–3.88 (m, 3H), 3.80 (s, 3H), 3.65–3.60 (m, 1H), 3.59–3.53 (m, 1H), 2.01–
1.89 (m, 1H), 1.82–1.74 (m, 1H), 1.64–1.58 (m, 1H), 1.57–1.51 (m, 1H), 1.44–1.31 (m, 2H), 1.25–1.19 
(m, 1H), 0.94–0.90 (m, 21H), 0.11 (s, 3H), 0.09 (s, 3H), 0.06 (s, 6H). 
13C NMR (101 MHz, CDCl3): δ = 159.8, 131.7, 127.4, 113.5, 101.2, 78.9, 74.6, 67.2, 63.0, 55.3, 43.7, 
29.1, 27.6, 26.2, 26.0, 21.4, 18.5, 18.3, 14.6, –3.6, –4.4, –5.2, –5.3. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 =2955, 2929, 2856, 1518, 1463, 1249, 1104, 1039, 833, 775. 
HRMS (ESI) calc. for C29H54NaO5Si2+ [M+Na]+: 561.3402; found: 561.3393.  
[𝒂]𝑫
𝟐𝟎 = –7.9° (c = 0.54, CH2Cl2). 
 
  
 
 
Alcohol 281 
 
A solution of diisobutylaluminum hydride (1 M in toluene, 25.2 mL, 25.2 mmol, 6.00 equiv) was added 
to a solution of 280 (2.26 g, 4.19 mmol, 1 equiv) in dichloromethane (35 mL) at –78 °C. The reaction 
mixture was allowed to warm to –40 °C over a period of 3 h. The reaction mixture was diluted with 
diethyl ether (200 mL) and saturated aqueous sodium potassium tartrate solution (200 mL) were added. 
The biphasic mixture was stirred vigorously for 2 h. The layers were separated and the aqueous layer 
was extracted with diethyl ether (2 × 150 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (300 mL). The washed solution was dried over magnesium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash column chromatography on silica gel (10% ethyl acetate in cyclohexane) to give 281 (2.19 g, 97%) 
as a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.41 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.30–7.22 (m, 2H), 6.91–6.84 (m, 2H), 4.65 (d, J = 11.1 Hz, 1H), 4.38 
(d, J = 11.1 Hz, 1H), 4.03 (dd, J = 5.7, 2.1 Hz, 1H), 3.80 (s, 3H), 3.75–3.67 (m, 3H), 3.57 (dd, J = 10.3, 
3.9 Hz, 1H), 3.49 (dd, J = 10.3, 6.2 Hz, 1H), 2.54 (s, 1H), 1.95–1.86 (m, 1H), 1.72–1.64 (m, 1H), 1.64–
1.49 (m, 2H), 1.46–1.33 (m, 1H), 1.30–1.15 (m, 2H), 0.93–0.87 (m, 21H), 0.09 (s, 3H), 0.08 (s, 3H), 
0.06 (s, 6H). 
13C NMR (101 MHz, CDCl3): δ = 159.3, 130.6, 129.6, 114.0, 81.4, 73.2, 71.6, 62.6, 61.1, 55.4, 44.2, 
32.0, 29.4, 26.3, 26.0, 21.2, 18.6, 18.3, 14.6, –3.5, –4.8, –5.2, –5.4. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 =3440, 2954, 2929, 2856, 1514, 1248, 1050, 830, 773, 678. 
HRMS (ESI) calc. for C29H57O5Si2+ [M+H]+: 541.3739; found: 541.3729.  
[𝒂]𝑫
𝟐𝟎 = –9.8° (c = 0.32, CH2Cl2). 
  
 
 
Aldehyde 278 
 
Dess–Martin periodinane (1.36 g, 2.57 mol, 1.30 equiv) was added to a solution of 281 (1.39 g, 
2.57 mmol, 1 equiv) in dichloromethane (30 mL) at 0 °C. After 15 min, the white suspension was 
allowed to warm to 23°C. After 2 h, the reaction mixture was directly purified by flash column 
chromatography on silica gel (10% ethyl acetate in cyclohexane) to give 278 (1.30 g, 94%) as a colorless 
oil. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.60 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.76 (dd, J = 2.8, 1.5 Hz, 1H), 7.25–7.20 (m, 2H), 6.88–6.82 (m, 2H), 
4.58 (d, J = 11.1 Hz, 1H), 4.41 (d, J = 11.1 Hz, 1H), 4.07 (ddd, J = 8.3, 3.4, 2.3 Hz, 1H), 4.02 (dd, J = 
5.6, 2.3 Hz, 1H), 3.79 (s, 3H), 3.59 (dd, J = 10.4, 3.7 Hz, 1H), 3.49 (dd, J = 10.4, 6.2 Hz, 1H), 2.71 (ddd, 
J = 17.0, 8.3, 2.8 Hz, 1H), 2.53 (ddd, J = 17.0, 3.4, 1.5 Hz, 1H), 1.57–1.43 (m, 2H), 1.42–1.33 (m, 1H), 
1.30–1.16 (m, 2H), 0.92–0.89 (m, 12H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 (s, 6H). 
13C NMR (101 MHz, CDCl3): δ = 202.5, 159.3, 130.5, 129.5, 113.8, 76.8, 73.7, 71.5, 62.3, 55.3, 44.7, 
44.6, 29.5, 26.2, 26.0, 21.1, 18.5, 18.3, 14.5, –3.6, –4.7, –5.3, –5.4. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2929, 2857, 1727, 1613, 1514, 1249, 1075, 832, 775. 
HRMS (ESI) calc. for C29H54NaO5Si2+ [M+Na]+: 561.3402; found: 561.3391. 
[𝒂]𝑫
𝟐𝟎 = –8.0° (c = 0.21, CH2Cl2). 
  
 
 
Diol α-284 and β-284 
 
Note: N,N-Dimethylformamide was degassed via freeze-pump-thaw (three cycles) prior to use. 
A mixture of chromium(II) chloride (2.08 g, 16.9 mmol, 7.00 equiv) and nickel(II) chloride (31.9 mg, 
241 µmol, 0.100 equiv) was added in one portion to a solution of 278 (1.30 g, 2.41 mmol, 1 equiv) and 
287 (4.56 g, 16.9 mmol, 7.00 equiv) in N,N-dimethylformamide (60 mL) at 0 °C. After addition, the 
dark green reaction mixture was allowed to warm to 23 °C. After 48 h, aqueous hydrochloric acid (1 M, 
200 mL) and ethyl acetate (200 mL) were added sequentially. The biphasic mixture was stirred 
vigorously for 15 min. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(2 × 150 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution (400 mL). The washed solution was dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (15% ethyl acetate in cyclohexane initially, grading to 30% ethyl acetate in cyclohexane) to 
give an inseparable mixture of α-284 and β-284 (609 mg, 41%) as a yellow oil. An analytically pure 
sample of α-284 and β-284 were obtained by normal-phase semi-preparative HPLC purification using 
5% iso-propanol in n-heptane as eluent (flow rate: 15 mL/min; column: Microsorb 60-8 Si Dynamax 
250 × 21.4mm (R00083121C); detection: 254 nm; retention time: α-284 10.5 min; β-284 9.32 min). 
For α-284 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.26 (UV, CAM). 
1H NMR (600 MHz, CDCl3): δ = 7.26–7.24 (m, 2H), 6.90–6.87 (m, 2H), 5.52 (q, J = 6.9 Hz, 1H), 4.89 
(d, J = 10.7 Hz, 1H), 4.70 (d, J = 10.7 Hz, 1H), 4.46 (s, 1H), 4.39 (d, J = 10.9 Hz, 1H), 4.34 (d, J = 11.9 
Hz, 1H), 4.07 (dd, J = 6.2, 1.6 Hz, 1H), 3.90 (d, J = 11.8 Hz, 1H), 3.83 (ddd, J = 9.4, 3.1, 1.6 Hz, 1H), 
3.81 (s, 3H), 3.54 (dd, J = 10.3, 4.0 Hz, 1H), 3.50 (dd, J = 10.3, 6.0 Hz, 1H), 3.10 (s, 1H), 2.18–2.09 (m, 
1H), 1.61 (d, J = 6.9 Hz, 3H), 1.61–1.56 (m, 1H), 1.54–1.50 (m, 1H), 1.47 (q, J = 6.5, 4.8 Hz, 1H), 1.43–
1.36 (m, 1H), 1.27–1.17 (m, 2H), 0.92–0.88 (m, 21H), 0.10 (s, 3H), 0.08 (s, 3H), 0.05 (s, 3H), 0.04 (s, 
3H). 
13C NMR (151 MHz, CDCl3): δ = 159.5, 141.2, 129.8, 129.8, 123.6, 114.1, 83.3, 73.1, 71.9, 70.2, 66.2, 
62.6, 55.4, 44.2, 35.5, 29.3, 26.3, 26.0, 21.1, 18.6, 18.4, 14.6, 13.2, –3.5, –4.8, –5.2, –5.3. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3406, 2955, 2929, 2857, 1514, 1250, 1077, 1038, 834, 775. 
HRMS (ESI) calc. for C33H62NaO6Si2+ [M+Na]+: 633.3977; found: 633.3950. 
[𝒂]𝑫
𝟐𝟎 = –8.5° (c = 0.26, CH2Cl2). 
  
 
 
For β-284 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.26 (UV, CAM). 
1H NMR (600 MHz, CDCl3): δ = 7.29–7.26 (m, 2H), 6.89–6.86 (m, 2H), 5.50 (q, J = 6.9 Hz, 1H), 4.89 
(dd, J = 9.6, 3.2 Hz, 1H), 4.66 (d, J = 11.3 Hz, 1H), 4.35 (d, J = 11.3 Hz, 1H), 4.30 (d, J = 11.9 Hz, 1H), 
4.07 (dd, J = 6.2, 1.9 Hz, 1H), 3.98 (d, J = 11.9 Hz, 1H), 3.81 (s, 3H), 3.72 (dt, J = 9.3, 2.6 Hz, 1H), 
3.57 (dd, J = 10.3, 4.0 Hz, 1H), 3.52 (dd, J = 10.3, 5.7 Hz, 1H), 2.46 (s, 2H), 1.73 (qdd, J = 14.7, 9.3, 
3.0 Hz, 2H), 1.62 (d, J = 6.9 Hz, 3H), 1.60 (dd, J = 7.4, 2.9 Hz, 1H), 1.49–1.44 (m, 1H), 1.39 (dp, J = 
10.4, 7.4, 5.8 Hz, 1H), 1.27–1.18 (m, 2H), 0.91 (s, 9H), 0.89 (s, 12H), 0.07 (s, 3H), 0.06 (s, 3H), 0.06–
0.04 (m, 6H).  
13C NMR (151 MHz, CDCl3): δ = 159.3, 141.2, 130.8, 129.6, 123.8, 114.0, 78.4, 73.3, 71.4, 68.0, 66.3, 
62.6, 55.4, 44.1, 36.4, 29.4, 26.3, 26.1, 21.1, 18.6, 18.4, 14.6, 13.2, –3.5, –4.8, –5.2, –5.3. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 =3365, 2955, 2929, 2857, 1514, 1249, 1040, 1005, 834, 775. 
HRMS (ESI) calc. for C33H62NaO6Si2+ [M+Na]+: 633.3977; found: 633.3919. 
[𝒂]𝑫
𝟐𝟎 = –32.3° (c = 0.17, CH2Cl2). 
  
 
 
Allylic alcohol α-288 and β-288 
 
Acetyl chloride (70.1 µL, 973 µmol, 1.05 equiv) was added to a solution of α-284 and β-284 (566 mg, 
926 µmol, 1 equiv) and 2,4,6-collidine (249 µL, 1.85 mmol, 2.00 equiv) in dichloromethane (9 mL) at           
–78 °C. After, 2.5 h, aqueous hydrochloric acid (1 M, 100 mL) and dichloromethane (80 mL) were 
added. The layers were separated and the aqueous layer was extracted with dichloromethane 
(2 × 80 mL). The combined organic extracts were dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (10% ethyl acetate in cyclohexane) to give an inseparable mixture of α-288 and β-288 (508 mg, 
84%) as a colorless oil. The mixture of diastereoisomers was partially characterized by HRMS and IR 
spectroscopy. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.47 (UV, CAM). 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 =3495, 2955, 2929, 2857, 1741, 1514, 1250, 1079, 835, 775. 
HRMS (ESI) calc. for C35H64NaO7Si2+ [M+Na]+: 675.4083; found: 675.4041.  
 
  
 
 
MOM-ether α-289 and β-289 
 
Bromomethyl methyl ether (705 µL, 7.78 mmol, 10.0 equiv) was added to a solution of 288 (508 mg, 
778 µmol, 1 equiv) and N-ethyl-N-isopropylpropan-2-amine (2.72 mL, 15.6 mmol, 20.0 equiv) in 
dichloromethane (10 mL) at 0 °C. after addition, the reaction mixture was allowed to warm to 23 °C. 
After 24 h, the reaction mixture was cooled to 0 °C and bromomethyl methyl ether (353 µL, 3.89 mmol, 
5.00 equiv) and N-ethyl-N-isopropylpropan-2-amine (1.36 mL, 7.78 mmol, 10.0 equiv) were added. 
After addition the reaction mixture was allowed to warm to 23 °C. After 24 h, the reaction mixture was 
cooled to 0 °C and bromomethyl methyl ether (353 µL, 3.89 mmol, 5.00 equiv) and N-ethyl-N-
isopropylpropan-2-amine (1.36 mL, 7.78 mmol, 10.0 equiv) were added. After addition the reaction 
mixture was allowed to warm to 23 °C. After 12 h, water (100 mL) and dichloromethane (80 mL) were 
added. The layers were separated and the aqueous layer was extracted with dichloromethane 
(2 × 90 mL). The combined organic extracts were dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (10% ethyl acetate in cyclohexane) to give an inseparable mixture of α-289 and β-289 (503 mg, 
93%) as a colorless oil. The mixture of diastereoisomers was partially characterized by HRMS and IR 
spectroscopy. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.57(UV, CAM). 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2929, 2857, 1743, 1514, 1248, 1091, 1034, 833, 775. 
HRMS (ESI) calc. for C37H68NaO8Si2+ [M+Na]+: 719.4345; found: 719.4335. 
  
 
 
Primary alcohol α-290 and β-290 
 
Pyridine hydrofluoride (~70% hydrogen fluoride, ~30% pyridine, 1.50 mL, 57.7 mmol, 80.0 equiv) was 
added to a solution of 289 (503 mg, 722 µmol, 1 equiv) and pyridine (10.5 mL, 130 mmol, 180 equiv) 
in tetrahydrofuran in a 50 mL Falcon® tube at 0 °C. After 1 h, the reaction mixture was allowed to warm 
to 23 °C. After 24 h, the reaction mixture was poured on a solution of saturated aqueous sodium 
bicarbonate solution (200 mL). Ethyl acetate (150 ml) was added and the biphasic mixture was stirred 
vigorously for 15 min. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(2 × 150 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution (400 mL). The washed solution was dried over magnesium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (15% ethyl acetate in cyclohexane initially, grading to 25% ethyl acetate in cyclohexane) to 
give α-290 (215 mg, 51%) as a colorless oil and β-290 (126 mg, 30%) as a colorless oil.  
For α-290 
TLC (40% ethyl acetate in cyclohexane): Rf  = 0.43 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.28–7.24 (m, 2H), 6.88–6.84 (m, 2H), 5.85 (q, J = 7.2, 6.6 Hz, 1H), 
4.82 (dd, J = 9.3, 5.3 Hz, 1H), 4.70 (d, J = 11.1 Hz, 1H), 4.62 (dt, J = 12.9, 1.2 Hz, 1H), 4.57–4.50 (m, 
2H), 4.47 (d, J = 6.5 Hz, 1H), 4.31 (d, J = 11.1 Hz, 1H), 3.98 (dd, J = 4.9, 2.2 Hz, 1H), 3.79 (s, 3H), 
3.68 (dd, J = 11.1, 3.8 Hz, 1H), 3.54 (dd, J = 11.1, 7.4 Hz, 1H), 3.51–3.47 (m, 1H), 3.34 (s, 3H), 2.22 
(s, 1H), 2.13–2.04 (m, 4H), 1.91 (ddd, J = 14.5, 9.3, 2.8 Hz, 1H), 1.76–1.69 (m, 1H), 1.67 (d, J = 7.2 
Hz, 3H), 1.50–1.38 (m, 2H), 1.32–1.23 (m, 2H), 0.93–0.85 (m, 12H), 0.08 (s, 3H), 0.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 171.0, 159.1, 132.9, 130.9, 129.7, 128.8, 113.8, 93.6, 79.5, 75.6, 71.9, 
69.5, 64.4, 62.7, 55.5, 55.4, 45.0, 35.2, 30.1, 26.1, 21.3, 21.2, 18.4, 14.5, 13.5, –3.9, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3509, 2955, 2927, 2856, 1740, 1514, 1248, 1093, 1035, 835. 
HRMS (ESI) calc. for C31H54NaO8Si+ [M+Na]+: 605.3480; found: 605.3464.  
[𝒂]𝑫
𝟐𝟎 = –20.3° (c = 0.16, CH2Cl2). 
  
 
 
For β-290 
TLC (40% ethyl acetate in cyclohexane): Rf  = 0.37 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.31–7.27 (m, 2H), 6.89–6.84 (m, 2H), 5.79–5.73 (m, 1H), 4.74 (dd, 
J = 10.6, 1.6 Hz, 2H), 4.54–4.48 (m, 3H), 4.43–4.35 (m, 2H), 3.99 (dd, J = 4.9, 1.6 Hz, 1H), 3.82–3.78 
(m, 4H), 3.75 (dd, J = 11.4, 3.3 Hz, 1H), 3.60 (dd, J = 11.4, 7.1 Hz, 1H), 3.35 (s, 3H), 2.81 (s, 1H), 2.03 
(s, 3H), 1.98–1.89 (m, 1H), 1.74–1.68 (m, 1H), 1.68–1.60 (m, 4H), 1.50–1.38 (m, 2H), 1.37–1.29 (m, 
2H), 0.94–0.89 (m, 12H), 0.08 (s, 3H), 0.07 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 171.0, 159.3, 134.6, 131.0, 129.4, 129.2, 113.9, 94.7, 78.9, 76.4, 72.7, 
70.5, 65.3, 62.1, 56.2, 55.4, 45.5, 37.3, 30.4, 26.1, 21.2, 21.2, 18.3, 14.5, 13.1, –4.0, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 3499, 2954, 2626, 2855, 1740, 1514, 1248, 1034, 1248, 1034, 834, 
775. 
HRMS (ESI) calc. for C31H54NaO8Si+ [M+Na]+: 605.3480; found: 605.3466.  
[𝒂]𝑫
𝟐𝟎 = –42.0° (c = 0.20, CH2Cl2) 
  
 
 
Aldehyde β-291 
 
Dess–Martin periodinane (118 mg, 279 µmol, 1.30 equiv) was added to a solution of β-290 (125 mg, 
214 µmol, 1 equiv) dichloromethane (1 mL) at 0 °C. After 30 min, the reaction mixture was directly 
purified by flash column chromatography on silica gel (20% ethyl acetate in cyclohexane) to give β-291 
(105 mg, 84%) as a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.43 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.76 (d, J = 2.1 Hz, 1H), 7.30–7.27 (m, 2H), 6.88–6.85 (m, 2H), 5.80–
5.70 (m, 1H), 4.73–4.67 (m, 2H), 4.53–4.50 (m, 2H), 4.48 (d, J = 6.7 Hz, 1H), 4.44 (d, J = 10.9 Hz, 1H), 
4.35 (d, J = 6.7 Hz, 1H), 4.19 (dd, J = 6.7, 2.1 Hz, 1H), 3.80 (s, 3H), 3.63 (dt, J = 10.1, 1.8 Hz, 1H), 
3.31 (s, 3H), 2.55–2.47 (m, 1H), 2.03 (s, 3H), 1.88–1.78 (m, 1H), 1.73–1.64 (m, 5H), 1.57–1.48 (m, 
1H), 1.46–1.36 (m, 1H), 1.35–1.23 (m, 1H), 0.94–0.87 (m, 12H), 0.08 (s, 3H), 0.05 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 204.4, 170.9, 159.2, 134.5, 130.9, 129.4, 129.1, 113.8, 94.6, 79.4, 
73.4, 72.5, 70.1, 65.1, 56.1, 55.4, 55.4, 36.6, 28.1, 26.1, 21.2, 21.0, 18.4, 14.4, 13.1, –3.8, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2955, 2930, 2856, 1737, 1463, 1247, 1089, 1026, 834, 776. 
HRMS (ESI) calc. for C31H52NaO8Si+ [M+Na]+: 603.3324; found: 603.3303. 
[𝒂]𝑫
𝟐𝟎 = –46.9° (c = 0.21, CH2Cl2) 
  
 
 
β-Ketoester β-293 
 
Ethyl diazoacetate (292) (84.9 µL, 702 µmol, 4.00 equiv) and tin(II) chloride (20.0 mg, 105 µmol, 
0.600 equiv) were sequentially added to a solution of β-291 (102 mg, 176 µmol, 1 equiv) in 
dichloromethane (0.4 mL). After 12 h, water (20 mL) and dichloromethane (20 mL) were added. The 
layers were separated and the aqueous layer was extracted with dichloromethane (2 × 20 mL). The 
combined organic extracts were dried over magnesium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel (15% 
ethyl acetate in cyclohexane) to give β-293 (58.4 mg, 50%) as a colorless oil.  
Note: β-293 was isolated as keto/enol-tautomers (2:1). In the 1H NMR spectrum only well separated 
signals for the keto-tautomer are reported. In the 13C NMR all peaks of both tautomers are reported. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.34 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 4.45 (d, J = 6.7 Hz, 1H), 3.79 (s, 3H), 2.80–2.69 (m, 1H), 2.04 (s, 
3H). 
13C NMR (101 MHz, CDCl3): δ = 206.59, 178.26, 172.75, 170.97, 166.97, 159.17, 159.12, 134.84, 
134.44, 131.01, 130.86, 129.50, 129.43, 129.01, 128.31, 113.79, 113.71, 94.64, 94.54, 92.09, 78.73, 
78.42, 74.11, 73.14, 71.60, 71.09, 70.12, 70.00, 65.13, 65.01, 61.61, 61.17, 60.09, 56.15, 55.72, 55.43, 
55.36, 55.34, 51.80, 49.80, 35.79, 35.31, 32.22, 31.58, 26.25, 26.19, 21.23, 20.56, 20.48, 18.59, 18.51, 
14.42, 14.41, 14.29, 14.22, 14.17, 13.06, 13.03, –3.53, –3.66, –4.81, –4.89. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2957, 2932, 2857, 1741, 1465, 1247, 1230, 1155, 1032, 835. 
HRMS (ESI) calc. for C35H58NaO10Si+ [M+Na]+: 689.3691; found: 689.3661.  
  
 
 
Aldehyde α-295 
 
Dess–Martin periodinane (190 mg, 448 µmol, 1.30 equiv) was added to a solution of α-290 (201 mg, 
214 µmol, 1 equiv) dichloromethane (1 mL) at 0 °C. After 1 h, the reaction mixture was directly purified 
by flash column chromatography on silica gel (20% diethyl ether in n-pentane) to give α-295 (177 mg, 
89%) as a colorless oil. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.47 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 9.71 (d, J = 2.2 Hz, 1H), 7.27–7.23 (m, 2H), 6.88–6.84 (m, 2H), 5.86 
(q, J = 7.0 Hz, 1H), 4.79 (dd, J = 8.5, 6.0 Hz, 1H), 4.61 (d, J = 11.2 Hz, 1H), 4.56–4.52 (m, 3H), 4.45 
(d, J = 6.6 Hz, 1H), 4.33 (d, J = 11.2 Hz, 1H), 4.23 (dd, J = 6.1, 2.9 Hz, 1H), 3.79 (s, 3H), 3.35–3.29 
(m, 4H), 2.53–2.46 (m, 1H), 2.06 (s, 3H), 2.05–1.97 (m, 1H), 1.83 (ddd, J = 14.5, 8.5, 3.2 Hz, 1H), 1.74–
1.66 (m, 2H), 1.65 (d, J = 7.0 Hz, 3H), 1.44–1.34 (m, 1H), 1.30–1.22 (m, 1H), 0.92–0.87 (m, 12H), 0.09 
(s, 3H), 0.02 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 204.4, 170.8, 159.1, 132.8, 130.7, 130.3, 128.9, 113.8, 93.6, 79.4, 
73.0, 71.5, 69.1, 64.3, 55.6, 55.4, 55.3, 34.4, 27.8, 26.1, 21.2, 21.0, 18.4, 14.3, 13.5, –3.8, –4.8. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2955, 2931, 2857, 1741, 1514, 1248, 1094, 1034, 836, 777. 
HRMS (ESI) calc. for C31H52NaO8Si+ [M+Na]+: 603.3324; found: 603.3311.  
[𝒂]𝑫
𝟐𝟎 = +18.0° (c = 0.10, CH2Cl2) 
  
 
 
β-Ketoester α-296 
 
Ethyl diazoacetate (292) (101 µL, 702 µmol, 3.00 equiv) and tin(II) chloride (26.5 mg, 139 µmol, 
0.500 equiv) were sequentially added to a solution of α-295 (102 mg, 176 µmol, 1 equiv) in 
dichloromethane (0.5 mL). After 12 h, water (20 mL) and dichloromethane (20 mL) were added. The 
layers were separated and the aqueous layer was extracted with dichloromethane (2 × 20 mL). The 
combined organic extracts were dried over magnesium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel (10% 
diethyl ether in n-pentane) to give α-296 (125 mg, 67%) as a colorless oil.  
Note: α-296 was isolated as keto/enol-tautomers (2:1). In the 1H NMR spectrum only well separated 
signals for the keto-tautomer are reported. In the 13C NMR all peaks of both tautomers are reported. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.43 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 5.87–5.81 (m, 1H), 3.80 (s, 3H), 3.50 (d, J = 3.9 Hz, 2H), 3.33 (s, 
3H), 3.17–3.12 (m, 1H), 2.77 (td, J = 8.4, 4.1 Hz, 1H). 
13C NMR (101 MHz, CDCl3): δ = 205.74, 178.32, 172.61, 170.85, 167.06, 159.06, 159.00, 133.06, 
132.84, 130.90, 130.79, 129.88, 129.59, 128.86, 128.81, 113.78, 113.72, 93.61, 93.53, 91.72, 79.39, 
78.74, 73.95, 73.20, 71.23, 70.70, 69.40, 69.30, 64.51, 64.41, 61.28, 60.19, 55.56, 55.45, 55.37, 55.37, 
55.36, 55.31, 50.66, 49.66, 34.44, 33.99, 31.77, 31.20, 26.27, 26.19, 21.24, 21.20, 20.56, 20.53, 18.61, 
18.48, 14.42, 14.36, 14.26, 14.16, 13.46, 13.36, –3.50, –3.74, –4.88, –4.91. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2956, 2932, 2858, 1742, 1711, 1514, 1230, 1033, 835, 777. 
HRMS (ESI) calc. for C35H58NaO10Si+ [M+Na]+: 689.3691; found: 689.3684.  
  
 
 
Allyl bromide α-276 
 
Potassium carbonate (74.6 mg, 540 µmol, 3.00 equiv) was added to a solution of α-296 (118 mg, 
177 µmol, 1 equiv) in methanol (2 mL). After 24 h, water (50 mL) and diethyl ether (50 mL) were 
added. The layers were separated and the aqueous layer was extracted with diethyl ether (2 × 50 mL). 
The combined organic extracts were washed with saturated aqueous sodium chloride solution (150 mL). 
The washed solution was dried over magnesium sulfate. The dried solution was filtered and the filtrate 
was concentrated. The residue was filtered through a plug of silica and the obtained crude product (α-
297) was used without further purification. 
 
N-Bromosuccinimide (38.2 mg, 212 µmol, 1.20 equiv) was added to a solution of crude α-297 (108 mg, 
177 µmol, 1 equiv) and triphenylphosphine (56.3 mg, 212 µmol, 1.20 equiv) at –30 °C. After 1 h, n-
pentane (2 mL) was added and the white suspension was directly purified by flash column 
chromatography on silica gel (5% diethyl ether in n-pentane initially, grading to 30% diethyl ether in n-
pentane) to give α-276 (77.3 mg, 65% over 2 steps) as a colorless oil. 
Note: α-276 was isolated as keto/enol-tautomers (2:1). In the 1H NMR spectrum only well separated 
signals for the keto-tautomer are reported. In the 13C NMR all peaks of both tautomers are reported. 
TLC (30% ethyl acetate in cyclohexane): Rf  = 0.49 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 6.09 (q, J = 7.1 Hz, 1H), 3.81 (s, 3H), 3.54 (s, 2H), 3.35 (s, 3H), 2.87–
2.80 (m, 1H). 
13C NMR (101 MHz, CDCl3): δ = 205.53, 178.60, 172.91, 167.51, 159.05, 159.03, 134.96, 134.84, 
134.04, 133.31, 130.77, 130.77, 128.88, 128.75, 113.80, 113.75, 93.73, 93.71, 91.39, 79.39, 78.61, 
73.95, 73.22, 71.34, 70.68, 70.06, 69.94, 55.49, 55.46, 55.39, 55.36, 55.36, 52.28, 51.33, 50.54, 49.45, 
34.59, 34.04, 33.00, 32.93, 31.68, 31.05, 26.26, 26.19, 20.57, 20.51, 18.61, 18.47, 14.33, 14.10, 13.87, 
13.83, –3.51, –3.69, –4.86, –4.93. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2954, 2931, 2857, 1751, 1712, 1514, 1246, 1028, 834, 776. 
HRMS (ESI) calc. for C32H53BrNaO8Si [M+Na]+: 695.2585; found: 695.2562.  
  
 
 
Cyclization products α-301 and α-302 
 
Diazabicycloundecene (20.2 µL, 134 µmol, 2.00 equiv) was added to a solution of α-276 (45.0 mg, 
66.8 µmol, 1 equiv) in acetonitrile (3.5 mL). After 12 h, the yellow solution was diluted with diethyl 
ether (2 mL) and filtered through a plug of silica. The filtrate was concentrated and the residue was 
purified normal-phase semi-preparative HPLC purification using 1% iso-propanol in n-heptane initially, 
grading to 3% iso-propanol over in n-heptane over 45 min as eluent (flow rate: 15 mL/min; column: 
Microsorb 60-8 Si Dynamax 250 × 21.4mm (R00083121C); detection: 254 nm; retention time: α-301 
6.7 min; α-302 8.7 min) to give α-301 (10.0 mg, 25%) as a colorless oil and α-302 (12.3 mg, 32%) as a 
colorless oil. 
For α-301 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.42 (UV, CAM). 
1H NMR (600 MHz, CDCl3): δ = 12.94 (s, 1H), 7.17–7.12 (m, 2H), 6.82–6.78 (m, 2H), 5.67 (q, J = 7.3 
Hz, 1H), 4.60 (dd, J = 8.3, 6.0 Hz, 1H), 4.57–4.51 (m, 2H), 4.35 (d, J = 11.4 Hz, 1H), 4.27 (d, J = 11.4 
Hz, 1H), 3.91 (d, J = 9.9 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.35 (s, 3H), 3.18–3.13 (m, 2H), 3.09–3.04 
(m, 1H), 2.74 (d, J = 15.6 Hz, 1H), 2.40–2.34 (m, 1H), 1.83–1.77 (m, 1H), 1.77–1.71 (m, 1H), 1.70–
1.63 (m, 1H), 1.51 (d, J = 7.1 Hz, 3H), 1.35–1.25 (m, 1H), 1.13–1.06 (m, 1H), 0.90 (s, 9H), 0.87 (t, J = 
7.3 Hz, 3H), 0.07 (s, 3H), 0.06 (s, 3H). 
13C NMR (151 MHz, CDCl3): δ = 175.5, 174.0, 159.1, 138.6, 130.5, 129.9, 126.9, 113.7, 102.4, 93.5, 
77.8, 74.2, 72.2, 70.4, 55.5, 55.4, 51.7, 45.1, 32.9, 31.0, 26.3, 26.3, 20.6, 18.7, 14.3, 13.6, –3.4, –4.7. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2996, 2897, 2847, 1597, 1635, 1211, 1187, 1048, 866, 774. 
HRMS (ESI) calc. for C32H52NaO8Si [M+Na]+: 615.3324; found: 615.3279.  
 
 
  
 
 
For α-302  
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.23 (UV, CAM).  
1H NMR (600 MHz, CDCl3): δ = 7.22 (d, J = 8.3 Hz, 2H), 6.87–6.83 (m, 2H), 5.79–5.69 (m, 1H), 4.74–
4.66 (m, 1H), 4.53–4.47 (m, 1H), 4.47–4.41 (m, 1H), 4.40–4.33 (m, 1H), 4.26–4.19 (m, 1H), 4.02 (d, J 
= 9.0 Hz, 1H), 3.79 (s, 3H), 3.70 (s, 3H), 3.62–3.56 (m, 1H), 3.35 (s, 3H), 3.01–2.94 (m, 1H), 2.87–2.75 
(m, 2H), 2.41–2.31 (m, 1H), 2.18–2.10 (m, 1H), 1.90–1.80 (m, 1H), 1.74–1.64 (m, 1H), 1.56–1.50 (m, 
1H), 1.48–1.42 (m, 3H), 1.21–1.09 (m, 2H), 0.89–0.82 (m, 12H), 0.04 (s, 3H), 0.02 (s, 3H). 
13C NMR (151 MHz, CDCl3): δ = 208.7, 168.8, 159.3, 132.1, 131.1, 130.4, 129.6, 113.8, 93.3, 75.4, 
71.0, 70.7, 64.5, 55.6, 55.4, 52.4, 51.0, 33.9, 32.1, 26.7, 26.2, 26.0, 19.3, 18.7, 14.4, 13.0, –3.4, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2953, 2930, 2856, 1640, 1609, 1245, 1144, 1033, 835, 777. 
HRMS (ESI) calc. for C32H52NaO8Si [M+Na+]+: 615.3324; found: 615.3291.   
  
 
 
Chloride α-304 
 
A solution of potassium 1,1,1-trimethyl-N-(trimethylsilyl)silanaminide (1 M in tetrahydrofuran, 
38.1 µL, 38.1 µmol, 2.00 equiv) was added to a solution of α-301 and α-302 in tetrahydrofuran (0.5 mL) 
at –78 °C. After 45 min, frifluoromethanesulfonyl chloride (4.06 µL, 38.1 µmol, 2.00 equiv) was added 
and the reaction mixture was allowed to warm to 23 °C. After 10 min, two drops of saturated aqueous 
sodium bicarbonate solution were added and the mixture was filtered through a plug of silica. The filtrate 
was concentrated and the residue was purified normal-phase semi-preparative HPLC purification using 
1% iso-propanol in n-heptane initially, grading to 3% iso-propanol over in n-heptane over 45 min as 
eluent (flow rate: 15 mL/min; column: Microsorb 60-8 Si Dynamax 250 × 21.4mm (R00083121C); 
detection: 190 nm; retention time: 6.2 min) to give α-304 (7.2 mg, 62%) as a colorless. 
TLC (20% ethyl acetate in cyclohexane): Rf  = 0.42 (UV, CAM). 
1H NMR (400 MHz, CDCl3): δ = 7.25–7.21 (m, 2H), 6.88–6.83 (m, 2H), 6.10 (qd, J = 7.1, 1.6 Hz, 1H), 
4.63 (dd, J = 12.1, 5.4 Hz, 1H), 4.49 (d, J = 6.5 Hz, 1H), 4.45–4.39 (m, 2H), 4.30 (d, J = 11.2 Hz, 1H), 
4.09 (dd, J = 8.4, 1.9 Hz, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.40 (d, J = 15.5 Hz, 1H), 3.35 (s, 3H), 3.29 
(dt, J = 8.8, 5.1 Hz, 1H), 3.04–2.93 (m, 1H), 2.69 (d, J = 15.5 Hz, 1H), 2.04–1.94 (m, 1H), 1.93–1.79 
(m, 3H), 1.49–1.41 (m, 4H), 1.39–1.28 (m, 1H), 0.91 (t, J = 7.3 Hz, 3H), 0.88 (s, 9H), 0.03 (s, 3H), 0.02 
(s, 3H). 
13C NMR (101 MHz, CDCl3): δ = 205.2, 169.5, 159.3, 134.9, 130.6, 129.5, 129.5, 113.9, 93.1, 76.3, 
74.4, 74.0, 71.5, 71.0, 55.6, 55.4, 53.7, 51.4, 37.0, 34.1, 32.4, 26.3, 19.0, 18.7, 14.5, 13.3, –3.4, –4.9. 
IR (Diamond-ATR, neat): 𝜈𝑚𝑎𝑥 = 2955, 2932, 2856, 1748, 1514, 1248, 1083, 1027, 834, 777. 
HRMS (ESI) calc. for C32H51ClKO7Si [M+K]+: 649.2724; found: 649.2921.  
[𝒂]𝑫
𝟐𝟎 = +12.5° (c = 0.48, CH2Cl2) 
  
 
 
3.3.6 X-Ray Crystallographic Data 
Ferrocenecarboxylate ester 237 
 
 
 
Table 6 | Crystallographic data for 237. 
net formula C24H22FeO4 
Mr/g mol−1 430.26 
crystal size/mm 0.080 × 0.070 × 0.020 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 5.99760(10) 
b/Å 12.6528(3) 
c/Å 25.3750(7) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1925.62(8) 
Z 4 
calc. density/g cm−3 1.484 
μ/mm−1 0.812 
absorption correction Multi-Scan 
transmission factor range 0.6846–0.7454 
refls. measured 10370 
Rint 0.0328 
mean σ(I)/I 0.0446 
θ range 3.211–26.366 
observed refls. 3651 
x, y (weighting scheme) 0.0248, 0.2800 
hydrogen refinement constr 
Flack parameter 0.004(8) 
refls in refinement 3927 
parameters 263 
 
 
restraints 12 
R(Fobs) 0.0274 
Rw(F2) 0.0642 
S 1.041 
shift/errormax 0.002 
max electron density/e Å−3 0.461 
min electron density/e Å−3 −0.221 
 
 
  
 
 
Secondary alcohol 257 
 
 
 
Table 7 | Crystallographic data for 257. 
Empirical formula  C27H33 N O7 
Formula weight  483.54 
Temperature  183(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 (no. 4) 
Unit cell dimensions a = 9.4935(6) Å, α= 90°. 
 b = 27.1375(16) Å, β= 
90.337(2)°. 
 c = 9.9811(6) Å, γ = 90°. 
Volume 2571.4(3) Å3 
Z 4 
Density (calculated) 1.249 Mg/m3 
Absorption coefficient 0.090 mm-1 
F(000) 1032 
Crystal size 0.180 x 0.160 x 0.080 
mm3 
 
 
Theta range for data collection 2.145 to 24.499°. 
Index ranges -11<=h<=11, -
30<=k<=31, -11<=l<=11 
Reflections collected 37669 
Independent reflections 8413 [R(int) = 0.0558] 
Completeness to theta = 24.499° 99.8 %  
Absorption correction Semi-empirical from 
equivalents 
Max. and min. transmission 0.955 and 0.932 
Refinement method Full-matrix least-squares 
on F2 
Data / restraints / parameters 8413 / 3 / 642 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0460, wR2 = 
0.0938 
R indices (all data) R1 = 0.0772, wR2 = 
0.1029 
Absolute structure parameter 0.1(4) 
Extinction coefficient 0.0138(13) 
Largest diff. peak and hole 0.601 and -0.207 e.Å-3 
 
  
 
 
Silyl ether 258 
 
 
 
Table 8 | Crystallographic data for 258. 
Empirical formula  C33 H47 N O7 S 
Formula weight  601.77 
Temperature  183(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 (no. 4) 
Unit cell dimensions a = 15.6831(13) Å, = 
90°. 
 b = 7.1153(6) Å, = 
116.788(2)°. 
 c = 16.4777(13) Å,  = 90°. 
Volume 1641.4(2) Å3 
Z 2 
Density (calculated) 1.218 Mg/m3 
 
 
Absorption coefficient 0.145 mm-1 
F(000) 648 
Crystal size 0.210 x 0.180 x 0.080 
mm3 
Theta range for data collection 2.481 to 23.248°. 
Index ranges -17<=h<=17, -7<=k<=7, -
17<=l<=18 
Reflections collected 14339 
Independent reflections 4699 [R(int) = 0.0494] 
Completeness to theta = 23.248° 99.8 %  
Absorption correction Semi-empirical from 
equivalents 
Max. and min. transmission 0.958 and 0.888 
Refinement method Full-matrix least-squares 
on F2 
Data / restraints / parameters 4699 / 1 / 381 
Goodness-of-fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0478, wR2 = 
0.1100 
R indices (all data) R1 = 0.0699, wR2 = 
0.1184 
Absolute structure parameter 0.15(4) 
Extinction coefficient 0.013(3) 
Largest diff. peak and hole 0.201 and -0.399 e.Å
–3 
 
  
 
 
3.3.7 1H and 13C NMR Spectra 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
